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The burden of chronic diseases such as cancer is increasing in low and 
middle income countries around the globe.  Nepal, one of the world’s poorest 
countries, is no exception to this trend, with lung cancer as the leading causes of 
cancer deaths.   Despite this, limited data is available on the environmental and 
behavioral risk factors that contribute to the lung cancer etiology in Nepal.  The 
objectives of this dissertation are to: 1) investigate the ethnic differences in 
consumption of local tobacco products and their role in lung cancer risk in Nepal; 
2) evaluate urinary metabolite of 1,3-butadiene as a biomarker of exposure to 
combustion related household air pollution (CRHAP); 3) investigate the 
association between CRHAP exposure and lung cancer risk using urinary 
  
metabolite of 1,3-butadiene as a biomarker of exposure; 4) investigate the 
association between CRHAP exposure and lung cancer risk using questionnaire 
based measure of exposure.      
Lung cancer cases (n=606) and frequency matched controls (N=606) were 
recruited from B.P. Koirala Memorial Cancer Hospital. We obtained biological 
samples and information on lifestyles including cooking habits and type of fuels 
used. We used liquid chromatograph tandem mass spectrometer (LC-MS/MS) to 
quantify urinary metabolites of 1,3-butadiene in urine samples.  We employed a 
combination of logistic and linear regression models to detect any exposure-
disease associations while controlling for known confounding variables.    
Overall, we found that ethnic groups in Nepal use different tobacco 
products that have different differing cancer potency -we observed the highest 
odds ratios for the traditional tobacco products.  The biomarker analysis showed 
strong evidence that monohydroxybutyl mercapturic acid is associated with 
biomass fuel use among participants. However, we did not find significant 
association between urinary MHMBA and lung cancer risk. When we used 
questionnaire based measure of exposure to household air pollution, we observed 
significant, dose-response associations between CRHAP exposure and lung 
cancer risk, particularly among never-smokers.   
  
Our results show that important role of local tobacco products in lung 
cancer risk in Nepal. Furthermore, we demonstrate that CRHAP exposure is a risk 
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Chapter 1: Introduction 
 
Globally, cancer incidence is increasing with approximately 70% of 
cancer related deaths occurred in low and middle income countries (LMICs) 
(IOM, 2007).  In LMICs, lung cancer accounts for an estimated 1.37 million 
deaths annually and is the leading cause of cancer related mortality for men and 
third for women (WHO, 2012).  Lung cancer is one of the most common cancer 
in both men and women in Nepal, one of the poorest countries in the world, 
accounting for 20% of all cancer cases (Binu et al., 2007; Pradhananga et al., 
2009; “World Bank Nepal Data,” 2012).  The influence of tobacco on lung cancer 
is well known, but the differential potency of various tobacco products, such as 
hand rolled traditional bidi or choor/kankat that are commonly used in Nepal, 
remain unclear (Notani et al., 1977; Pednekar et al., 2011; Prasad et al., 2010, 
2009).   
Besides tobacco smoke, environmental exposures are major sources of 
morbidity and mortality across the globe. A recent study on the global burden of 
disease has identified combustion related household air pollution (CRHAP) as a 
critical and worsening environmental health concern (Lim et al., 2012), 
contributing to over 3.5 million deaths worldwide.  Burning biomass fuels such as 





CRHAP exposures have been associated with both chronic and acute health 
outcomes including various cancers, low birth weight, increased respiratory 
infection, cataracts, and cardiovascular complications (Bruce et al., 2015; Martin 
et al., 2013; Naeher et al., 2007, 2005; Sapkota et al., 2013).   The components of 
CRHAP include many chemicals that are known or suspected to be carcinogenic.  
CRHAP emissions contain particulate matter, sulfur oxides, nitrogen oxides, 
carbon monoxide, polycyclic aromatic hydrocarbons, formaldehyde, and dioxins 
(Ding et al., 2012; EPA, 2007; Ward et al., 2008). The carcinogenicity of CRHAP 
resulting from biomass fuels was extensively evaluated by expert panel convened 
by the International Agency for Research on Cancer (IARC). Based on the 
available epidemiological studies at the time, the panel concluded that CRHAP 
resulting from combustion of coal was a known human carcinogen (Group 1). The 
group concluded that CRHAP resulting from combustion of biomass was a 
probable human carcinogen (Group 2A). The panel cited lack of epidemiological 
studies related to CRHAP from biomass as the main reason for the Group 2A 
classification (IARC, 2010a).   
In light of myriad health outcomes related to CRHAPs resulting from 
combustion of biomass, researchers have been investigating various ways to 
quantify individual level measure exposure to CRHAP that can be used in 
epidemiological studies.   Biological markers (biomarkers) are attractive option as 





pathways. Biomarker also provide a measure of absorbed dose, rather than 
potential dose, and account for inter-individual variability related to occupation, 
home environment, and time activity pattern. For CRHAP exposure, many 
biomarkers have been proposed, but none have achieved the desired specificity 
and sensitivity  (Rylance et al., 2013; Simpson and Naeher, 2010).  Two urinary 
metabolites of 1,3-butadiene – monohydroxybutyl mercapturic acid (MHBMA) 
and dihydroxybutyl mercapturic acid (DHBMA) have been used as a biomarker 
of exposure to combustion related pollution in both occupational and 
environmental settings (Albertini et al., 2001; Richard J Albertini et al., 2003; 
Fustinoni et al., 2004; Gustafson et al., 2007; Ruchirawat et al., 2010; Sapkota et 
al., 2006). Others have suggested MHMBA and DHMBA as a potential biomarker 
of exposure to CRHAP exposure.          
We propose to address these questions using hospital based case-control 
study conducted in Nepal. Our specific aims are:     
 
Specific Aim 1: investigate the ethnic differences in consumption pattern of local 
tobacco products and their role in lung cancer risk in Nepal. 
 
Hypothesis 1-1: Traditional tobacco products will increase lung cancer risk more 






Specific Aim 2: Evaluate MHBMA and DHMBA as biomarker of exposure to 
CRHAP from biomass combustion.   
 
Hypothesis 2-1: Participants who use biomass for cooking will have higher 
urinary concentration of MHMBA and DHMBA.  
 
Specific Aim 3: Quantify the risk of lung cancer associated with CRHAP 
using biomarker based measure of exposure 
 
Specific Aim 4: Quantify risk of lung cancer associated with CRHAP using 
questionnaire based measure of exposure. 
 
Hypothesis 3-1: Long term exposure to CRHAP resulting from biomass 




Results from this study will provide first ever quantitative estimate of the role of 
local tobacco product and CRHAP exposure on lung cancer etiology in Nepal. 
The data will help inform local public health policies designed to address the 







 This dissertation is organized into 7 distinct chapters.  The overall 
dissertation aims, objectives, and hypotheses is presented in Chapter 1.  
Introductory material including an overview of chronic diseases and specifically 
lung cancer in low and middle income countries (LMICs) is contained in the 
Background section (Chapter 2).  Also contained in Chapter 2 includes a review 
of the current literature surrounding household air pollution (CRHAP) from 
biomass cooking fuels, human exposure to CRHAP, and measuring personal 
exposure via biomarkers.  Also included in this chapter is a review of the 
literature and background material about traditional tobacco products and 
associated health outcomes.  Lastly, Chapter 2 includes background material 
surrounding the details of this present study and data collection protocols. 
 
 Chapter 3 is the first peer-reviewed manuscript that investigates lung 
cancer risk associated with traditional tobacco use as mediated by ethnic group 
(Raspanti et al., 2015).  This manuscript addresses a large research gap focusing 
on differential tobacco use among ethnic groups in Nepal and how various 
tobacco use patterns differentially influence lung cancer within these groups.  We 
analyzed tobacco use by focusing on traditional tobacco (bidi, choor/kankat, and 





cigarettes).  The analysis was stratified by self-identified ethnic group to 
determine lung cancer effect modification across these sub populations.   
 
Chapter 4 is a draft of the manuscript that focuses on measuring personal 
exposure to CRHAP from biomass cooking fuels.  Here, we used the primary 
metabolites of 1,3 butadiene, which is a known human carcinogen, to estimate 
personal-level dose as related to cooking fuel.  These mercapturic acids have been 
used to measured personal exposures from a variety of sources including traffic 
and occupational origins.  Using these well validated biomarkers, we gained 
insight into personal exposures to this known carcinogen derived from cooking 
fuels and cooking behaviors in Nepal.  The association between these metabolites 
and lung cancer risk provides a significant advancement in measuring and 
understanding CRHAP exposures faced by billions of people around the world.  
 
Chapter 5 is a draft manuscript expanding on the biomarker analysis in the 
previous chapter.  We utilized the urinary biomarker data derived from the 
previous chapter and analyzed the association with lung cancer risk.  Utilizing 
data collected from the study participants, we were able to control for many 
known environmental and behavioral contributions to observed biomarker 
concentrations.  Major challenges exist in using a transient biomarker to be 





opportunity to use the metabolites of 1,3 butadiene as associated with lung cancer 
risk.  By understanding this association, we can contribute to unveiling the 
pathway starting from initial CRHAP exposure to carcinogenesis. 
 
Chapter 6 is a peer-reviewed manuscript investigating lung cancer risk 
associated with CRHAP exposures from biomass cooking fuels (Raspanti et al., 
2016).  In this manuscript, we created lifetime profiles of cooking fuel usage 
across all reported residences.  We calculated total years of exposure to biomass 
cooking fuels (coal, wood, biomass, and kerosene) and modern fuels (natural gas 
and electricity) and compared lung cancer risk associated with usage of these 
fuels among a highly exposed population.  Our analysis was stratified by tobacco 
usage to reduce the influence of this well-established cocktail of carcinogens.  
Here, we were able to confidently attribute lung cancer risk to biomass cooking 
fuel exposure in a dose-response manner.  These results contribute significantly to 
understanding the impact of biomass cooking fuels and negative health outcomes 
in LMICs. 
 
Lastly, Chapter 7 provides an overall synthesis of the dissertation as 
organized by each previous chapter.  This synthesis contains an improved view of 
lung cancer in Nepal through the results of this dissertation.  Also, we discuss the 






Chapter 2: Background 
 
Common misperceptions exists that low income areas only need to focus 
valuable and often limited resources on immediate, infectious disease response; 
however, chronic disease account for an estimated 50% of disease burden within 
low and middle income countries.  Recent estimates by the WHO estimate that 
nearly 80% of chronic disease burden lie in low and middle income countries 
(WHO, 2010).  In fact, this increasing burden of disease can potentially cost $84 
billion USD in economic production in these highly impacted areas (Abegunde et 
al., 2007).   While these perceptions are not entirely misplaced, chronic diseases, 
such as cancer, are often overlooked or not fully understood.  Major catalysts in 
the battle to combat, control, and reduce chronic diseases in these regions is 
unequal distribution of resources and access to high quality health care in a timely 
manner (Ebrahim et al., 2013; Fitzmaurice et al., 2015; Miranda et al., 2008; 
Nugent, 2008; WHO, 2010).  While the plight of low income areas are often 
viewed through the historical lens of development among current high income 
areas, it is incorrect to view this process linearly and homogenous.  Similar 
intervention and development strategies that work in one area of the world will 
not necessarily be as successful elsewhere.  Cultural, social, and other contextual 





(Aikins et al., 2012; Di Cesare et al., 2013).  While large scale education aimed at 
behavior change have been attempted, small scale efforts that increase local 
capacity and infrastructure may be the most appropriate response given the global 
climate (Pisani, 2011).     
 
Lung Cancer Burden in LMICs 
Mortality from cancer is on the rise, particularly among low and middle 
income countries around the world (IARC, 2012; WHO, 2012).  Of the estimated 
8.2 million deaths globally attributed to cancer, approximately 70% occurred in 
low and middle income countries  (Frenk, 2009; WHO, 2012). It has been 
postulated that these numbers grossly under estimate the true burden of cancers in 
the developing world.  Lack of access to preventive medical care as well as lack 
of access to care following cancer detection can severely increase mortality due to 
cancer.  Furthermore, the increase in life expectancy, increased caloric intake, and 
other unhealthy habits have increased cancer rates in the developing world.  
Economic development has also been associated with increasing cancer incidence 
due to an increase in occupational and environmental exposures (Hashim and 
Boffetta, 2014; Lee and Hashibe, 2014).  Other social indicators such as poverty, 
educational attainment, and family income have been shown to influence cancer 
incidence and mortality (de Vries et al., 2014; INCTR, 2014).   Along with lack of 





and other missing health infrastructure, cancer has and will continue to devastate 
the developing world (INCTR, 2014; WHO, 2010).      
 
Often, low and middle income countries bear the largest burden of disease 
as shown in Figure 1.  In most of these areas, lung cancer is the leading 
contributor to cancer deaths accounting for an estimated 1.59 million deaths 
(IARC, 2012).  Majority of these cases are related to tobacco smoking, which 
accounts for roughly 22% of global cancer deaths and 71% of lung cancer deaths 
(Beaglehole et al., 2011; IOM, 2007; WHO, 2012).  It has been estimated that up 
to one billion deaths can be adverted with targeted, global tobacco control efforts 
(Beaglehole et al., 2015).   While tobacco use in high income areas is declining 
due to increased income and awareness, low income area are just entering the 
“tobacco epidemic” and smoking rates are expected to increase (Chiosi et al., 
2015; Kuper et al., 2002; Lee and Hashibe, 2014; Martiniuk et al., 2010).  Not 
only has tobacco smoking been commonly associated with lung cancer, but recent 
data confirm the influence of tobacco smoking on a variety of cancers 
(Beaglehole et al., 2015; WHO, 2015).  Along with the well documented potency 
of tobacco, growing concern surrounding environmental contributions to lung 
cancer risk has been highlighted in recent publications (Bruce et al., 2015; Gordon 





improved cancer prevention strategies, IARC estimates that 2 million lives could 
be saved by 2020 and 6.5 million by 2040 (IARC, 2012).   
Figure 1: Projected Deaths by Major Cause (WHO, 2005) 
 
Lung Cancer Treatment in Nepal 
Lung cancer is one of the most common cancer in both males and females 
in Nepal – one of the poorest countries in the world with 30 million people – 
accounting for 20% of all cancer cases (Binu et al., 2007; Pradhananga et al., 
2009; “World Bank Nepal Data,” 2012).  Historically, cancer rates have been 
difficult to estimate due to poor cancer registry systems in Nepal.  In 1991, Bir 
Hospital located in the capital city of Kathmandu was founded and offered 
rudimentary cancer services which included chemotherapy and surgery (Subedi 





on the part of the Nepalese government to prioritize health care to the highly rural 
Nepalese population.  This effort has not been without setbacks.  With poverty 
and limited education in much of the country, improving basic health care 
services and access has proven challenging, not to mention cancer prevention and 
control efforts.  The vast majority of cancer services are concentrated in the 
Central, Kathmandu areas with limited reach to other parts of the country.  Most 
recent estimates highlight B.P. Koirala Memorial Cancer Hospital (BPKMCH) as 
the top cancer treatment facility, serving the most cases in the county (Piya and 
Acharya, 2012; Subedi and Sharma, 2012).  BPKMCH was founded in 1999 as a 
collaborative effort between the government of Nepal and the government of 
China to improve the oncology gap in Nepal (Piya and Acharya, 2012).  This 
comprehensive cancer center boasts the top technological approaches to cancer 
care in the entire country.  As observed in Figure 2, cancers of the trachea and 
lung are the leading cancers in 4 out of the 6 cancer centers in the country.  In 
BPKMCH, cancers of the trachea and lung rank second behind cancer of the 









Figure 2: Most Common Cancers by Hospital in Nepal (adapted from 
Subedi & Sharma, 2015)  
 
Major challenges still exist in cancer treatment, control, and prevention in 
Nepal.  One of the most important challenges is reaching the often remote rural 
populations.  Nepal is known for its rough and unforgiving terrain and with an 
estimated 90% of the population living in rural areas, major efforts need to be 
made to provide improved basic health care to these regions.  Secondly, the cost 
of care can further restrict those in rural poverty to break into the health care 
system.  Lastly, extending health communication and education surrounding 
behavior change (ex. Tobacco cessation) to these populations remains a challenge 
(Farmer et al., 2010; Piya and Acharya, 2012).  Given the challenges faced, large 
opportunities arise to make significant impacts on cancer in Nepal.  Namely, 





ability to greatly reduce many forms of cancer.  A prime example would be an 
increased effort to reduce or eliminate tobacco use among Nepalese youth to 
attenuate ballooning lung cancer rates (Piya and Acharya, 2012; Subedi and 
Sharma, 2012).  With great challenges comes great opportunity.   
     
CRHAP Exposure from Biomass Fuels and Lung Cancer Risk 
 
Overall, global biomass fuel use in the home for primary cooking purposes 
is estimated between 40-52% or approximately 2.8 billion people (Lim et al., 
2012; Rehfuess et al., 2006).  Estimates of global biomass fuel use ranges from 
77% in African regions to less than 5% in developed nations (Rehfuess et al., 
2006). Many components of CRHAP emissions are either known or suspected 
human carcinogens.  The pyrolysis of organic material creates emissions that 
contain particulate matter, sulfur oxides, nitrogen oxides, carbon monoxide, 
polycyclic aromatic hydrocarbons, volatile organic compounds, formaldehyde, 
and dioxins (Abdullahi et al., 2013; Ding et al., 2012; EPA, 2007; Lim and Seow, 
2012; Ward et al., 2008).  In addition, the pyrolysis of coal emits lead, arsenic, 
and fluorine (Abdullahi et al., 2013; Desai et al., 2004).  This influence of 
CRHAP emitted from burning biomass fuels on health is disproportionately 





understand and quantify the relationship between CRHAP exposures and health 
outcomes. 
  
Recent publications have identified household air pollution, or CRHAP, to 
be a significant contributor to lung cancer and other pulmonary and 
cardiovascular illnesses (Barregard et al., 2008, 2006; Boman et al., 2003; Ganesh 
et al., 2011; Kampa and Castanas, 2008; Kurmi et al., 2012; Lam et al., 2012; Lee 
et al., 2013; Lim et al., 2012; Lim and Seow, 2012; Mortimer et al., 2012; Naeher 
et al., 2007, 2005; Rehfuess et al., 2009; Rylance et al., 2013). More specifically, 
about 3.5 million direct premature deaths from indoor exposures and 0.5 million 
deaths from outdoor air pollution caused by CRHAP, totaling nearly 4 million 
deaths annually is attributed to CRHAP (Lim et al., 2012).  The effects are 
especially drastic in low and middle income regions where CRHAP is cited as the 
most important single environmental risk factor (Lim et al., 2012).  Traditionally, 
the impact of using biomass fuels have disproportionately impacted women and 
children (Bates et al., 2013; Delfino et al., 2006; Desai et al., 2004; Epstein et al., 
2013).  Furthermore, the effects of using biomass fuels can extend to 
environmental degradation, global climate change, increased outdoor air 
pollution, and increased social inequalities (Gorin et al., 2006; IARC, 2010a). 
Previous research has clearly established the negative health impacts 





infection, decreased lung function, aggravated asthma, irregular heartbeat, various 
cancers, heart attacks, and premature death in people with preexisting heart and 
lung diseases, inflammation, oxidative stress, neurologic development in children, 
and many others (Barregard et al., 2008, 2006; Delfino et al., 2006; Hashibe et al., 
2010; Hejl et al., 2013; Lim and Seow, 2012; Sapkota et al., 2013, 2008; Seow et 
al., 2014; Stockfelt et al., 2012).  Recent research has proposed that acute wood 
smoke exposure may have immunotoxic effects by impairing the pulmonary 
macrophages, effectively increasing the infection rates (Naeher et al., 2005; 
Rylance et al., 2015).  Similarly, recent studies have shown increased urinary 
mutagenicity indicating DNA damage and mutation in those using biomass 
cooking fuels (Long et al., 2014).  A number of various exposure assessment 
strategies have been used to estimate wood smoke exposure.  Ambient air 
monitoring provides insight into the chemical composition of the air in a desired 
area which is very useful in large scale research projects.  This method fails to 
provide accurate personal exposure measurements and ultimately no information 
regarding internal dose. Personal exposure measurements are taken in the 
individual’s breathing zone which is generally defined as within 30 cm of the 
participant’s nose and/or mouth (Nieuwenhuijsen, 2003).  This method provides 
greater precision regarding potential personal exposure compared with ambient 
air monitoring; however, this does not provide information about internal dose.  





and time commitments.  By far, the most effective and accurate method to 
measure wood smoke exposure is through measuring biomarkers.   
 
Potential Biomarkers for CRHAP Exposure  
Figure 3: Biomass Exposure Pathway 
 
As defined by the EPA, biomarkers are measureable substances or 





chemical in the body, biological responses, or adverse health effects (EPA, 2012).  
Various biomarkers and the associated metabolic pathways have been 
investigated to measure wood smoke exposure in different human media.  The 
most common method has been through urine samples.  The research and need to 
identify an appropriate biomarker that can quickly and accurately quantify wood 
smoke exposure has been growing; however, no consensus has been reached in 
the scientific community on an appropriate urinary biomarker.  Numerous studies 
have investigated urinary levoglucosan, polycyclic aromatic hydrocarbon 
metabolites, and volatile organic compound metabolites as potential indicators of 
wood smoke exposure, which traditionally has focused on the use of wood stoves 
in the home for cooking and heating purposes in acute exposure settings (Boman 
et al., 2003).  These previous studies have yielded conflicting results into 
appropriate urinary biomarkers of wood smoke exposure.  There has been no 
comprehensive evaluation of these biomarkers in high exposure settings which 
provides the greatest insight into urinary biomonitoring of wood smoke exposure.  
The need to develop a useful and effective wood smoke biomarker can advance 
current research knowledge and have the potential to reduce respiratory illnesses 
and even death.  Ideally, a biomarker of wood smoke should include the following 
characteristics: 1) It should be uniquely derived from wood smoke; 2) it should be 
a relatively abundant constituent of wood smoke, such that ambient exposure 





the parent compound should be chemically stable in the environment, and the 
compound and it’s metabolites should be chemically stable in biological samples 
(Naeher et al., 2005).  In this project, we investigated wood smoke biomarkers 
with the goal of characterizing the effects of CRHAP and traditional tobacco 
products on lung cancer risk in Nepal. 
Polycyclic Aromatic Hydrocarbon Metabolites 
 
A large number of wood smoke related biomarkers have been 
investigated, but none have been identified as a universal target to measure wood 
smoke exposure conclusively.  Depending on the health outcome of interest, 
many types of biomarkers in various media have been investigated.   A popular 
biomarker to quantify wood smoke exposure has been urinary PAH metabolites 
(Kato et al., 2004; Nethery et al., 2012; Pruneda-Álvarez et al., 2012; Wang et al., 
2008).  Such metabolites are easily quantified in urine samples and can indicate 
an increased risk for cardiovascular illness and potential carcinogenic risk 
(Ruchirawat et al., 2010).  Most notably, 1-hydroxypyrene and 2-naphthol are 
commonly used PAH metabolites tested in urine.  Kato and colleagues concluded 
that urinary 2-naphthol was the most sensitive indicator of wood smoke exposure 
in a group of charcoal workers in Brazil (Kato et al., 2004).  In a group of healthy 
women in Mexico, 1-hydroxypyrene levels were higher in women who use 





Furthermore, a study conducted in Peru focusing on pregnant women found that 
levels of OH-PAH metabolites, such as 2-hydroxy-fluorene and 3-hydroxy-
fluorene, were significantly higher in women who exclusively used wood as a 
primary heating and cooking fuel when compared with groups who used natural 
gas or other combination of fuels (Adetona et al., 2013).  When the women in 
Peru are compared to results from the 3rd National Health and Nutrition 
Examination Survey, women cooking with wood in Peru had 8 times higher 1-
hydroxypyrene levels (Adetona et al., 2013).  Also, using high efficiency wood 
stoves can greatly reduce the levels of 1-hyroxypyrene levels found in urine 
(Torres-Dosal et al., 2008).   
 
Difficulties arise to conclusively identify wood smoke exposure due to the 
many sources of PAHs in the ambient air.  Smoking, exposure to environmental 
tobacco smoke, car traffic, occupational exposure, and even diet can influence an 
individual’s exposure to PAHs (Aquilina et al., 2010; Nethery et al., 2012; 
Siwińska et al., 1999).  Although identifying PAH metabolites in human samples 
does indicate exposure to some sort of combusted organic material, it proves very 
difficult to conclusively identify wood smoke as the primary exposure.  Similar to 
many other compounds, PAH exposure can occur via other routes besides 
inhalation and it has been suggested that inhalation may be the lowest contributor 







A second popular group of biomarker for wood smoke exposure is the 
methoxyphenol class of compounds.  Methoxyphenols are byproducts of the 
burning of lignin which binds to cellulose in wood and contributes to the strength 
and hardness of wood (Clark, 2004).  Emerging research shows promise in using 
urinary methoxyphenols to examine exposure to wood smoke.  Not all 
methoxyphenol compounds are appropriate to use as biomarkers for wood smoke 
exposure (Clark et al., 2007; Dills et al., 2006; Neitzel et al., 2009).  In a study 
conducted of healthy adults in Seattle who reported no exposure to wood smoke, 
guaiacol, 4-methylguaiacol, eugenol, and vanillin were found in all urine samples 
collected (Dills et al., 2001).  Such results indicate that there exist some 
background level of certain methoxyphenols and exposure may be universal to 
some extent.  The type of wood burned also contributes to the type of 
methoxyphenol biomarkers in urine.  When hardwood is burned, the levels of 
urinary syringols are predominant, while the burning of softwood increase the 
level of urinary guaiacols (Dills et al., 2001).  Geographic variations in type of 
wood use burned for fuel would complicate direct comparisons of exposure.  
Urinary methoxyphenols were found to be highly correlated with carbon 





Similar to other biomarkers, methoxyphenols are highly influenced by dietary 




Carboxyhemoglobin found in blood is a result of carbon monoxide 
binding to hemoglobin in red blood cells.  Carbon monoxide is a common 
byproduct of incomplete combustion processes.  The concentration of carbon 
monoxide following the burning of organic material is extensive and can 
potentially be used as a biomarker for wood exposure.  The reduction of blood 
carboxyhemoglobin levels were observed after the instillation of high efficiency 
wood burning stoves when compared to using open fires (Torres-Dosal et al., 
2008).  Similarly, indoor levels of CO have been shown to be significantly 
reduced by installing a simple chimney stove (Smith et al., 2011, 2010; Smith-
Sivertsen et al., 2009).  However, carboxyhemoglobin levels are also very highly 
associated with smoking and second hand smoke exposure, complicating the 
relationship to wood smoke exposure.               
  






Levoglucosan is a byproduct of burning cellulose which is common in 
wood (Migliaccio et al., 2009).  Furthermore, levoglucosan has shown promise 
for its specificity to wood smoke.   Levoglucosan is noted as being emitted in high 
concentrations from wood burning, it is associated almost exclusively with 
aerosols, and it is stable and non-reactive in the atmosphere for at least 10 days 
(Fraser and Lakshmanan, 2000; Yttri et al., 2005).    Also, levoglucosan is not 
found in the smoke of lignite or semibitumious coal, but has been identified in 
small concentrations of cigarette smoke (Fabbri et al., 2008; Nolte et al., 2001; 
Simoneit et al., 1999). Urinary levoglucosan was found to be excreted rapidly 
from the body after exposure with a half-life of about 7 hours leaving a short 
window for sample collection (Moshammer et al., 2012).  A recent study of the 
emissions from burning various types of wood has observed and quantified 
similar concentrations of levoglucosan in all types of wood examined.  This 
indicates that levoglucosan can be used to examine wood smoke exposure in 
various geographic regions due to the universal presence in all types of wood 
smoke (Fine et al., 2002).  This yields great promise in the use of levoglucosan as 
a biomarker of wood smoke exposure that can be used on a global scale compared 
with methoxyphenols.   
 
One potential downside to urinary levoglucosan is the metabolic similarity 





into urinary levoglucosan effectively overestimating wood smoke exposure; 
however, Migliacco and colleagues concluded that glucose metabolism does not 
influence urinary levoglucosan concentrations (Migliaccio et al., 2009).  
Subsequently, the ingestion of caramel candy and other similar products are often 
treated as confounding variables (Bergauff et al., 2010; Moshammer et al., 2012).  
A major limiting factor is the uncertainty surrounding the metabolism of 
levoglucosan in humans.  A recent study suggests that levoglucosan is excreted 
quickly and chemically unchanged (Moshammer et al., 2012).  Furthermore, 
levoglucosan is a major organic component of particulate matter 2.5 and there 
seems to be background levels present in all urine samples reducing the ability to 
accurately quantify wood smoke exposure (Bergauff et al., 2010; Gorin et al., 
2006).  It has been estimated that levoglucosan is the main constituent in fine 
particulate emissions from wood burning, contributing about 18%-30% of the 
organic fine particulate emissions (Schauer et al., 2001).  Alternatively, another 
study has determined that using levoglucosan alone is not sufficient to use as an 
indication of ambient wood smoke contributions to PM, rather levoglucosan 
needs to be used in tandem with other chemical components of wood smoke 
(Hedberg et al., 2006).  Urinary levoglucosan has been proposed to be an 
indication of PAH exposure specifically in areas where wood is a primary fuel 
source as well (Wallner et al., 2013).  Levoglucosan is also present in the 





al., 2005).  Urinary levoglucosan has shown great promise in areas where wood is 
the major fuel source however some concerns remain about urinary levoglucosan 
as an effective biomarker for wood smoke exposure due to high variability in 
human diets (Bergauff et al., 2010; Fabbri et al., 2008; Hinwood et al., 2008; 
Rylance et al., 2013).  In low and middle income countries, the use of EPA 
certified wood stoves has shown significant reduction in indoor airborne 
levoglucosan levels when compared with open fires indicating the strong 
relationship between levoglucosan and wood smoke (EPA, 2007).   Strong 
evidence exists for levoglucosan to be used as a urinary biomarker for wood 
smoke exposure; however, many limiting factors and conflicting studies have 
decreased the scientific consensus.  
 
 Metabolites of 1,3 Butadiene 
 
Due to the carcinogenicity of 1,3 butadiene, the ability to accurately 
measure human exposure and associated health risk is necessary in many different 
settings.  1,3 butadiene is a colorless gas mainly used in rubber production and 
plastic manufacturing (ATSDR, 2012).  An estimated 6 billion pounds of 1,3 
butadiene is produced annually in the United States with another 600 million 
pounds imported (ATSDR, 2012).  An estimated 60% of this manufactured and 





car and truck tires (ATSDR, 2012).  It is released into the environment via 
industrial release, but also commonly released as a byproduct of gasoline 
combustion in vehicles.  A noted natural source of 1,3 butadiene is forest fires, 
but most environmental contributions are of anthropogenic origins.  1,3 butadiene 
has an environmental half-life of about 6 hours and is highly volatile (ATSDR, 
2012).  The vast majority of human exposure is via inhalation and 1,3 butadiene is 
further absorbed into the bloodstream.  On its own, 1,3 butadiene is not 
carcinogenic or biologically reactive, but is it bioactivated into carcinogenic 
products as shown in Figure 4 (R J Albertini et al., 2003).   
Figure 4: Toxicokinetics of 1,3 Butadiene (R J Albertini et al., 2003) 
 
 
Catalyzed predominately by cytochrome P450 2E1, 1,3 butadiene is 





second pathway detoxifies BDO via hydrolysis and glutathione S-transferase 
create 1,2-dihydroxy-3-butene (BD-diol) (Richard J Albertini et al., 2003; 
ATSDR, 2012).  BD-diol and BDO2 can both be transformed in 1,2 Dihydroxy 
3,4 epoxybutane or BDO-diol.  BDO, BDO-diol, and BDO2 all have the ability to 
interact with proteins including DNA causing DNA adducts leading to mutations 
and ultimately carcinogenesis if left unresolved (Richard J Albertini et al., 2003; 
ATSDR, 2012).  The estimated biological clearance of 1,3 butadiene is about 10 
hours following inhalation (ATSDR, 2012).   Monohydroxy-3-butenyl 
mercapturic acid (MHBMA) and 1,2-dihydroxybutyl mercapturic acid (DHBMA) 
are two major metabolites of 1,3 butadiene commonly measured in urine 
highlighted in Figure 5 (Albertini et al., 2001; Boogaard et al., 2001; Fustinoni et 













Figure 5: Highlighted Detoxification of 1,3 Butadiene into Major Urinary 
Metabolites [REFs] 
 
According the EPA’s Integrated Risk Information System, the chronic 
airborne reference concentration is set at 0.9 ppb (EPA, 2014).  This is based 
mouse models of developmental and reproductive outcomes as there is no human 
based data on these health endpoints.  Recently, the EPA has changed their 
classification of 1,3 butadiene from a “probable human carcinogen” to conclude 
that there exists “sufficient evidence” based on occupational epidemiologic 
studies that 1,3 butadiene is carcinogenic to humans with the proposed target 
organ to be the lymphohematopoietic system due to evidence of increased 
lymphoma and leukemia (Richard J Albertini et al., 2003; EPA, 2014).  Other 





ppm and a short term exposure limit of 5 ppm for 15 min (OSHA, 2013).  While 
industry is the main avenue for environmental release, growing evidence has 
identified residential wood combustion as another source of concern.     
 
Recent publications have shown that indoor 1,3 butadiene levels are 
higher among those who burn wood for cooking and/or heating subsequently 
increasing personal exposure (Gustafson et al., 2007; Sällsten et al., 2006).  
Difficulties arise when targeting MHBMA/DHBMA as they are ubiquitous in the 
ambient air.  Similar to other biomarkers, both metabolites are created from the 
combustion of organic material not specific to wood smoke.  Other sources of 
MHBMA/DHBMA include industrial processes, vehicle emissions, tobacco 
smoke, and dietary influences (Albertini et al., 2001; ATSDR, 2012; Gustafson et 
al., 2007; Sapkota et al., 2006; Soeteman-Hernández et al., 2013).  The ubiquitous 
presence of 1,3 butadiene raises concern about the usefulness of 
MHBMA/DHBMA as indicators of wood smoke.  Much of the research has 
focused on 1,3 butadiene exposures in occupational settings, which are not 
generalizable to the general population (Albertini et al., 2001; Richard J Albertini 
et al., 2003; Boogaard et al., 2001; Sapkota et al., 2006).  The main advantage of 
using MHBMA/DHBMA is the validated and established laboratory methods 
(Osterman-Golkar and Bond, 1996; Sapkota et al., 2006; Schettgen et al., 2009; 





appropriate in areas heavily influenced by vehicle traffic and industrial sources; 
however, such metabolites may be useful in low and middle income agricultural 
populations.  Rural areas, especially in low and middle income countries, are less 
impacted by vehicle traffic and industrial sources compared with large urban 
centers.  These geographic and socio-economic characteristics allow the research 
team to investigate MHBMA/DHMBA as indicators of wood smoke exposure.  
Role of Local Tobacco Products on Lung Cancer Risk 
Mortality from cancer is on the rise, particularly among low and middle 
income countries around the world (WHO, 2012).  Lung cancer is the leading 
contributor to cancer deaths accounting for an estimated 1.59 million deaths 
(WHO, 2012).  Majority of these cases are related to tobacco smoking, which 
accounts for roughly 22% of global cancer deaths and 71% of lung cancer deaths  
(IOM, 2007; WHO, 2012).  However, there is considerable variability in the type 
of tobacco products used, particularly in the low income countries.  
Understanding the risk associated with these local tobacco products is important 
to inform more meaningful and culturally competent intervention strategies.  
 
Increasing body of literature suggests that the potency of these local 
tobacco products is not similar (IARC, 2010b).  For example, traditional tobacco 





products (WHO, 2008).  Bidi cigarettes are hand-rolled loose tobacco contained 
within a leaf, commonly found in India and Southeast Asia (WHO, 2008).  The 
amount of tobacco used and inhalation rates and volumes vary dramatically even 
within individuals making it difficult to estimate personal usage.  As with 
commercial cigarettes, bidi smoke contains a wide range of known and suspected 
carcinogens, including the highly addictive nicotine (Prasad et al., 2009; WHO, 
2008).  Bidi usage has been strongly connected with socioeconomic status.  
Usually, they are offered as a cheaper alternative to commercial tobacco products 
and used predominately by rural, low income populations.  Often these 
populations have limited access to health care or tobacco cessation efforts (WHO, 
2008).  Furthermore, bidi usage has been associated with diabetes, cardiovascular 
health effects, and various cancers (Ganesh et al., 2011; Gupta et al., 2001; 
Jussawalla and Jain, 1979; Kolappan, 2002; NHRC, 2010; Notani et al., 1977; 
Pais et al., 2000; Prasad et al., 2009; WHO, 2008).   
 
Several studies from India have shown that bidi smoking is associated 
with higher risk of lung cancer risk compared to commercial cigarettes (Dikshit 
and Kanhere, 2000; Ganesh et al., 2011; Gupta et al., 2001; Jussawalla and Jain, 
1979; Notani and Sanghvi, 1974; Notani et al., 1977; Prasad et al., 2010; Sharma 
and Bansal, 2013; WHO, 2008).  The relationship between tobacco smoking and 





tobacco products in low and middle income countries is less certain.  Differences 
in health perceptions may increase in the use of these traditional tobacco products 
as they as incorrectly deemed safer than commercial products (WHO, 2008).  
Similarly, the frequency of use, variation in inhalation volume and force, and 
amount of tobacco per each “cigarette” will influence carcinogenesis (IARC, 
2010b; O’Connor, 2012; Pednekar et al., 2011).   
 
A brief examination of our pilot data revealed that there is considerable 
variation in smoking habits between gender and ethnic subgroups as well as 
geographical region.  Males are known to smoke more frequently and for longer 
duration compared to women (Chawla et al., 2010; Noronha et al., 2012).   
Variability in female smoking prevalence is linked to how smoking is perceived 
across the subgroups.  Among Brahmins and Chettris, smoking by females is 
considered socially unacceptable in contrast to Rai/Limbu/Magar/Tharu/Other 
where smoking is more acceptable.  In addition to the differences in smoking 
prevalence across ethnic subgroups, there is considerable difference in the type of 
local tobacco products consumed by these subgroups.   
Hospital-based Lung Cancer Study in Nepal 
Nepal is a dynamic and diverse country where tobacco use and exposure 





design and study population is large and diverse enough to generalize our findings 
to Nepal as a whole.  This provides a unique opportunity to investigate these 
major environmental concerns on a country-level with large scale implications.  
We have confidence that our approach can be duplicated in other low and middle 
income countries allowing for country-specific analysis of environmental 
contributions to lung cancer resulting in targeted and culturally competent public 
health interventions.  Overall, we are confident that our investigation into 
environmental contributions to lung cancer risk in Nepal can serve as a basis for 
targeted public health interventions aimed at exposure reduction.  Removing or 
reducing household air pollution and tobacco exposure can drastically increase the 
health of the Nepali population. 
 
 
A hospital-based case-control study was conducted at the B.P. Koirala 
Memorial Cancer Hospital (BPKMCH), located in the city of Bharatpur, Chitwan 
District, Nepal, from November 2009 through December 2012.  Located 150 
kilometers southwest of Kathmandu, BPKMCH is the major cancer hospital in 
Nepal.  The details regarding participant recruitment and biological sample 
collections have been described previously (Hashibe et al., 2010; Raspanti et al., 
2015).  In brief, 606 incident lung cancer cases and 606 age and gender matched 





The inclusion criteria for a lung cancer case were as follows: 1) they are 
18 years of age or older 2) they are a resident of Nepal for at least five years and 
3) they were admitted to BPKMCH.  The eligible cases were recruited as soon as 
possible following lung cancer diagnosis with a target interval of one day and a 
maximum interval of 4 weeks.  A trained medical staff reviewed medical records 
to extract relevant diagnostic information, including the date and method of 
diagnosis, histological type, tumor location, stage, and grade.  Final diagnosis of 
lung cancer was confirmed with histological, cytological, or X-ray based 
evidence.  The control population was selected from various hospital visitors to 
frequency match the distribution of the case population by age, sex, ethnicity, and 
residence.  The controls were visitors at BPKMCH excluding, family members of 
participating lung cancer cases.  Prior to field implementation, standardized 
lifestyle and food frequency questionnaires were translated into Nepali language 
by native speakers and pilot tested in the field.  Locally trained interviewers 
collected information on demographic characteristics, education, residential 
mobility throughout lifetime, type of cooking and heating fuel used at each 
residence, occupational history, and family history of cancer.  The study was 
approved by the Institutional Review Board at the University of Utah, University 






Biological samples were collected from all study participants following 
informed consent and administration of the questionnaire.  The samples collected 
include urine, blood, hair, nail, and buccal swabs from all study participants.  
Samples were collected according to a standardized protocol by trained hospital 
staff members.  The samples were stored in -80° C freezers on site until transport 
to the University of Maryland.  The samples were shipped on dry ice and arrived 
at the University of Maryland Exposure Assessment laboratory in the School of 
Public Health.  The biological samples were immediately transferred to -80° C 
freezers in the laboratory until analysis.  Samples were thawed at room 
temperature prior to analysis.      
The goal of this dissertation is to investigate environmental contributions 
to lung cancer in Nepal.  The first manuscript focuses on tobacco as a contributor 
to lung cancer.  This manuscript investigates the differential effects of traditional 
tobacco products and commercial tobacco products on lung cancer risk.  
Furthermore, we investigated the relationship between tobacco smoking patterns 
of ethnic subgroups and the contribution to overall lung cancer risk.  The second 
manuscript aims to explore household air pollution originating from biomass 
cooking fuel use contributes to lung cancer risk.  Here, we categorize fuel use into 
modern and biomass cooking fuel types and we analyze how duration and type of 
biomass cooking fuel use can influence lung cancer risk.  Lastly, our final 





pollution derived from biomass cooking fuels.  Using novel laboratory methods 
and analysis, this study fills a large research gap in measuring personal household 
air pollution exposure.  Together, these three manuscripts provide insight into 
major environmental causes of lung cancer risk in Nepal.   
 
This study is highly significant to public health as it deals with an 
important environmental exposure (CRHAP) affecting over 3 billion people as 
well as health outcome (lung cancer) that continues to be a leading cause of 
cancer mortality.  Our findings will further the understanding of the role of 
CRHAP exposure in the carcinogenesis of the lung.  Results will provide an 
impetus for targeted interventions that can potentially reduce lung cancer 
mortality in Nepal.  Furthermore, an effective biomarker to quantify wood smoke 
exposure has not been identified and recent publications have identified this 
research gap (Clark et al., 2013; Martin et al., 2013; Rylance et al., 2013).  This 
study will have a high public health impact because it will result in: 1) the 
identification of a useful and effect biomarker used to quantify wood smoke 
exposure 2) the quantification of lung cancer risk resulting from using biomass 
fuel use.  The larger implications related to household air pollution may yield the 
greatest public health impact as this project can propel wood smoke exposure 






   
Chapter 3: Ethnic Variability in Consumption of Traditional 
Cancer Products and Lung Cancer Risk in Nepal 
Raspanti, G.A., Hashibe, M., Siwakoti, B., Wei, M., Thakur, B.K., Pun, C.B., 
Milrod, C., Adhikari, S., Lee, Y.-C.A., Sapkota, A., 2015. Ethnic Variation in 
Consumption of Traditional Tobacco Products and Lung Cancer Risk in 




Lung cancer is the leading contributor to cancer deaths in the developing 
world. Within these countries, significant variability exists in the prevalence of 
lung cancer risk, yet limited information is available whether some of the 
observed variability is associated with differences in the consumption pattern of 
local tobacco products with differing potency.  We recruited 606 lung cancer 
cases and 606 frequency matched controls from the B.P. Koirala Memorial 
Cancer Hospital in Nepal from 2009-2012.  We estimated odds ratios (ORs) and 
95% Confidence Intervals (CI) for lung cancer risk associated with different 
tobacco products, using unconditional logistic regression.  Unfiltered cigarettes 
tended to be the most frequently used across ethnic subgroup with about 53.7% of 
Brahmin, 60,1% of Chettri, and 52.3% of Rai/Limbu/Magar/Other.  In contrast, 





27.7% who smoked unfiltered cigarettes.  Among those who only smoked one 
type of product, choor/kankat smokers had the highest lung cancer risk (OR 10.2; 
95% CI 6.2-16.6), followed by bidi smokers (OR 5.6; 95% CI 3.6-8.7), unfiltered 
cigarettes (OR 4.9; 95% CI 3.4-7.2), and filtered cigarettes (OR 3.4; 95% CI 2.2-
5.3).  A clear dose-response relationship was observed between increased 
frequency of smoking and lung cancer risk across all ethnic subgroups.  These 
results highlight the important role of traditional tobacco products on lung cancer 




Mortality from cancer is on the rise, particularly among low and middle 
income countries around the world (WHO, 2012).  Of the estimated 8.2 million 
deaths globally attributed to cancer, approximately 70% occurred in low and 
middle income countries (IOM, 2007; WHO, 2012).  In most of these areas, lung 
cancer is the leading contributor to cancer deaths accounting for an estimated 1.59 
million deaths (IARC, 2012).  Majority of these cases are related to tobacco 
smoking, which accounts for roughly 22% of global cancer deaths and 71% of 
lung cancer deaths (IARC, 2012; IOM, 2007; WHO, 2012).  However, there is 





low income countries.  With a projected increase in lung cancer in the region, 
understanding the lung cancer risk associated with these local tobacco products is 
important to inform more meaningful and culturally competent intervention 
strategies (Bhagabaty et al., 2015; D’Souza et al., 2013; Thapa and Sayami, 
2014).  
Lung cancer is the most common cancer in both males and females in 
Nepal – one of the poorest countries in the world with 30 million people – 
accounting for 20% of all cancer cases (Binu et al., 2007; Pradhananga et al., 
2009; “World Bank Nepal Data,” 2012).  Nepalese men are known to smoke more 
frequently and for longer duration compared to women (Chawla et al., 2010; 
Noronha et al., 2012).  Approximately, 52% of Nepalese men smoke some form 
of tobacco products, while 13% of women reported smoking tobacco (USAID, 
2012).  The most common used tobacco product in Nepal is filtered cigarettes 
accounting for approximately 30% of male smokers (USAID, 2012).  But there is 
considerable variation in female smoking prevalence across race and ethnicity as 
well as geographic areas.  This variability in female smoking prevalence is linked 
to how smoking is perceived across the subgroups.  Among Brahmins, smoking 
by females is considered socially unacceptable in contrast to 
Rai/Limbu/Magar/Other where smoking by females is more acceptable.  In 
addition to the differences in smoking prevalence across ethnic subgroups, there is 





subgroups.  Limited work has been conducted in Nepal, while an increasing body 
of literature suggests that the potency of these local tobacco products is not 
similar in neighboring India (Jayalekshmy et al., 2008; Noronha et al., 2012; 
Pednekar et al., 2011; Prasad et al., 2010, 2009). For example, several studies in 
India have shown that bidi smoking is associated with higher risk of lung cancer 
risk compared to commercial cigarettes (Dikshit and Kanhere, 2000; Ganesh et 
al., 2011; Gupta et al., 2001; Jussawalla and Jain, 1979; Notani and Sanghvi, 
1974; Notani et al., 1977; Prasad et al., 2010).  Smokers in Nepal use additional 
loose tobacco that they hand roll into a cigarette, commonly locally referred to as 
choor/kankat and cancer potency of suck products remains unknown.   
In this paper, we use data from hospital-based case control study from 
Nepal to i) quantify lung cancer risk associated with local tobacco products that 
are commonly used in Nepal (bidi and choor/kankat) versus commercial tobacco 
smoking (filtered and unfiltered cigarettes) and ii) investigate if the observed 
racial/ethnic differences in lung cancer risk in Nepal is associated with the 
differences in type of local tobacco product used.                                      
 
Materials and Methods 
A hospital-based case-control study was conducted at the B.P. Koirala 





District, Nepal, from November 2009 through December 2012.  Located 150 
kilometers southwest of Kathmandu, BPKMCH is the major cancer hospital in 
Nepal.  The details regarding participant recruitment and biological sample 
collections have been described previously (Hashibe et al., 2010).  In brief, 606 
incident lung cancer cases and 606 controls were recruited from the hospital after 
receiving informed consent.   
The inclusion criteria for a lung cancer case were: 1) 18 years of age or 
older 2) resident of Nepal for at least five years and 3) admitted to BPKMCH.  
The eligible cases were recruited as soon as possible following lung cancer 
diagnosis with a target interval of one day and a maximum interval of 4 weeks.  A 
trained medical staff reviewed medical records to extract relevant diagnostic 
information, including the date and method of diagnosis, histological type, tumor 
location, stage, and grade.  Final diagnosis of lung cancer was confirmed with 
histological, cytological, or X-ray based evidence.  The control population was 
selected from various hospital visitors to frequency match the distribution of the 
case population by age (+/-) 5 years, sex, ethnicity, and residence.  The controls 
were visitors at BPKMCH excluding, family members of participating lung 
cancer cases.  Prior to field implementation, standardized lifestyle and food 
frequency questionnaires were translated into Nepali language by native speakers 
and pilot tested in the field.  Locally trained interviewers collected information on 





type of cooking and heating fuel used at each residence, occupational history, and 
family history of cancer.  The study was approved by the Institutional Review 
Board at the University of Utah, University of Maryland as well as the 
Government of Nepal (Nepal Health Research Council).    
Tobacco use data was derived from questionnaires completed immediately 
following participant enrollment.  Participants were asked if they have smoked 
more than 100 cigarette/bidi/kankat/choor over their lifetime.  Non-smokers are 
classified as those who answered “no” to the aforementioned question and non-
smokers are used as the reference group during analysis.  If answered “yes”, the 
participant then reported the age of starting and stopping (if appropriate) and 
quantity used per day for each type of tobacco product individually.  We 
computed a lifetime profile of smoking habits based on duration and frequency of 
each type of tobacco products used.  Furthermore, these profiles were categorized 
to reflect single vs. multiple product users.  The type of tobacco products 
included: filtered cigarettes, unfiltered cigarettes, bidi, and choor/kankat. The last 
category (choor/kankat) is loose local tobacco products that individuals wrap 
themselves.   Dichotomous variables were created to reflect the use of each type 
of tobacco products. A variable reflecting duration and frequency of smoking was 
created for each product type [PACKYEARS = reported duration of smoking in 
years x frequency of smoking / 20].  These product specific PY variables were 





In addition, we also computed exposure to household air pollution derived 
from biomass cooking fuels (CRHAP) based on residential history and type of 
fuel used for cooking at each residence. We calculated a composite index of SES 
using scores for level of education, household income, and crowdedness (number 
of individuals living per room) as previously described (Ghosh and Ghosh, 2009; 
Sapkota et al., 2008)     
We used unconditional logistic regression to estimate the odds ratios 
(ORs) and 95% confidence intervals (95% CIs) for lung cancer risk associated 
with different traditional and commercial tobacco products and duration of 
tobacco use.  The models were adjusted for sex (male/female), ethnicity, zone of 
residence, age, CRHAP index, and SES index.  These potential confounding 
variables were chosen based on prior literature documenting their influence on 
lung cancer risk and smoking habits.  We considered adjusting for family history 
of lung cancer to account for the influence of genetic susceptibility.  However, 
only two individuals in the study reported a family member with lung cancer and 
in both instances the family members were smokers.           
 
Results 
The demographic characteristics of the study participants are provided in 





compared to 44% for females.  In general, cases tended to be slightly older and 
less educated compared to controls.  The vast majority of both cases (88%) and 
controls (91%) were Hindus.  The largest ethnic groups for cases were Chettri, 
Brahmin, Magar, and Madishe (20.5%, 19.3%, 17.3%, and 10.1% respectively).  
In comparison, the largest control groups were Brahmin, Chettri, Madishe, and 
Magar accounting for 25.2%, 17.2%, 12.9%, and 7.4% of the control population 
respectively.  The largest difference between cases and controls observed in this 
study was in the Magar caste, accounting for 17.3% of cases but only 7.4% of the 
controls.  About 23.7% of cases and 29.7% of controls are classified as “other”.  
Ethnic groups not included in the questionnaire include Janajati and Dalit groups 
as well as other smaller sub-populations not captured by the questionnaire 
options.     
Overall, the average years of tobacco use was 40.3 years.  Compared to 
controls, lung cancer cases significantly smoked tobacco longer (mean in years: 
55.2 vs. 25.5; p-value < 0.001) and more frequently (PY: 30.4 vs. 17.6; p-value < 
0.001). We observed variation in smoking prevalence and type of tobacco 
products used within ethnic subgroups (Table 3).  Ethnic subgroups were 
combined based upon cultural and geographical similarities. Across all subgroups, 
unfiltered cigarettes was the most frequently used tobacco product, with 
prevalence ranging from 60.1% of Chettri to 52.3% of Rai/Limbu/Magar/Other.  





predominant tobacco product was bidi (39.9%) followed by unfiltered cigarettes 
(27.7%). 
Not surprisingly, ever smokers had an increased risk of lung cancer when 
compared to those who reported never smoking (OR 4.95; 95% CI 3.50-7.01).  
We observed increased lung cancer risk among females compared with males 
(OR 1.76; 95% CI 1.34-2.36) and older participants (OR 1.05; 95% CI 1.03-1.06).  
Furthermore, we observed a decreasing lung cancer risk as SES increased (OR 
0.76; 95% CI 0.66-0.87). Overall, all types of tobacco product usage were 
independently associated with increased lung cancer risk compared with 
nonsmokers (Table 4).  Specifically we observed highest product specific risk for 
choor/kankat (OR 11.2; 95% CI 6.6-19.3) followed by bidi (OR 6.1; 95% CI 4.2-
9.1), unfiltered cigarettes (OR 5.6; 95% CI 3.9-8.1), and filtered cigarettes (OR 
4.2; 95% CI 2.8-6.2) when compared to nonsmokers.  Across ethnic subgroups, 
all tobacco products were associated with an increased lung cancer risk compared 
with non-smokers; however, the degree of the association varied by ethnic 
subgroup.  Among Brahmins the highest product specific OR was observed for 
choor/kankat, followed by bidi and unfiltered cigarettes [OR (95% CI) 11.7 (5.0-
27.4), 10.9 (5.1-23.1), 9.2 (4.5-18.7) respectively].  Chettri, Madishe/Tharu, and 
Rai/Limbu/Magar/Other groups showed similar patterns with the highest product 
specific ORs observed for choor/kankat [OR (95% CI) 9.1 (3.5-23.4), 14.1 (5.6-





15.8), 7.2 (3.4-35.9), and 5.2 (3.0-8.8) respectively] and unfiltered cigarettes [OR 
(95% CI) 5.6 (2.5-12.5), 6.1 (2.9-12.8), and 4.5 (2.7-7.4) respectively].   
We conducted sub analysis where multiple product users were assigned to 
a single product that was used for the longest duration. This did not change our 
overall findings significantly. Similarly to the previous analysis, the highest 
product specific ORs were observed for choor/kankat (OR 10.2; 95% CI 6.2-16.6) 
followed by bidi (OR 5.6; 95% CI 3.6-8.7) and unfiltered cigarettes (OR 4.9; 95% 
CI 3.4-7.2).  We observed the similar product specific effects when stratified 
across all ethnic subgroups.  
We detected associations between the number of tobacco products used 
and lung cancer risk (Table 5).  Lung cancer risk appeared to increase linearly 
with number of tobacco products consumed, with a noted exception for 
Madishe/Tharu groups (Table 5).  Overall, the highest observed OR was for those 
who reported using 3 or more types of tobacco products (OR 7.0; 95% CI 4.3-
11.4) compared with nonsmokers.  Similar trends were observed for every ethnic 
group with highest lung cancer risk among those reporting using 3 or more types 
of tobacco.           
To investigate if the frequency and duration of smoking has a different 
effect across the ethnic subgroups, we stratified the analysis for tobacco PY and 





response relationships between the tobacco PY and the risk of lung cancer 
(PTREND < 0.001).  We observed potential variability in the strength of association 
across ethnic subgroups. For example, the effect estimate for the highest exposure 
group (30+ PY) varied from 9.1 (CI 4.7-17.9) for Rai/Limbu/Other group to 23.7 
(CI 9.5-59.2) for Brahmin group.   
 
Discussion 
We analyzed data from a hospital based case-control study of lung cancer 
in Nepal to investigate possible differences in lung cancer risk across different 
ethnic subgroups with differences in smoking prevalence as well as the specific 
types of tobacco products consumed. 
We observed significant differences among the type of tobacco used by 
ethnic subgroups. Large percentages of Brahmin, Chettri, and 
Rai/Limbu/Magar/Other smokers used unfiltered cigarettes compared to 
Madishe/Tharu smokers who tended to use bidi.  Analysis focused on product 
specific effects showed those using choor/kankat had the highest risk followed by 
bidi and unfiltered cigarettes.  The differences observed between those smoking 
multiple types of tobacco products may be driven by underlying social and 





A clear exposure-response relationship was observed, both for number of 
tobacco smoked and tobacco-PY and lung cancer risk. This association persisted 
across ethnic subgroups. One surprising finding is the strength of association for 
duration of tobacco used and lung cancer risk across the ethnic subgroups. For the 
longest duration of exposure, the strongest effect was observed among Brahmins, 
although their prevalence of consumption for the two highest risk products 
(choor/kankat and bidi) was lower than the other groups. This is consistent with 
the product specific risk (Table 4) as well as the risk associated with number of 
tobacco products smoked.      
There are several strengths of this study.  This is the first study to provide 
local tobacco specific risk estimates on lung cancer risk among a very diverse and 
underserved population in Nepal.  The relatively large sample size allowed us to 
look at product specific risk.  There are some limitations associated with our study 
as well.  Mainly, complete independence was not achieved within the product 
specific tobacco categories.  Our aim was to identify the product specific lung 
cancer risk.  Secondly, the information regarding the tobacco types were assessed 
using a questionnaire, so potential recall bias cannot be ruled out.  Even though it 
may be difficult to directly compare all types of tobacco smoking, we can 
reasonably conclude that smoking traditional tobacco products increases the risk 






The implications of such results reinforce the dangerous health concerns 
surrounding smoking in low income countries.  More precisely, those who smoke 
traditional or local types of tobacco products are at a higher risk for lung cancer 
when compared to other types of tobacco smoking and nonsmoking groups.  The 
explanation of these differences may lie in the industrial processing of 
commercial tobacco compared to locally grown tobacco or that people may 
smoke traditional tobacco products more frequently due to misplaced perceptions 
of safety.  Filtering of commercial cigarettes may play a role as well, but does not 
fully explain the commercial unfiltered cigarettes.  While all tobacco products are 
harmful, our results show that the relative potency of the tobacco products is 
different.  While risk perception is relatively high surrounding the role of tobacco 
and lung cancer, risk perception about other health effects, namely heart disease 
and other cancers, related to tobacco use is comparatively low which allows room 
for improved health messaging surrounding tobacco use (Gupta and Johnson, 
2014; Gupta and Kumar, 2014; Peltzer and Pengpid, 2014).  This comprehensive 
evaluation of various tobacco products and smoking habits within ethnic groups 
in Nepal is the first of its kind and further research is needed to investigate the 







In summary, some variation was observed between types of tobacco used 
across ethnic groups.  Similarly, a marked variability was observed in the potency 
of local tobacco products, particularly choor/kankat.  Our findings suggest these 
cheaper products that smokers buy in bulk and roll themselves are more harmful.  
This poses a particular challenge since the extensive warning signs that have been 
used in the packaging materials to warn against the harm of tobacco products are 
not applicable for such loose products.  A separate intervention strategy is 
warranted to warn users of such cheap local products, who are more likely to be 
of low SES even by the LMIC standards. 
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Manuscript 1 Tables 
Table 2: Demographic Characteristics 
    Lung Cancer Cases Controls   
    N % N % Χ²  (p-value) 
 Age           98.5  (<0.001) 
  <40 27 4.5 24 3.9   
  40-49 45 7.4 121 19.9   
  50-59 152 25.1 231 38.1   
  60-69 251 41.4 179 29.5   
  70 + 131 21.6 51 8.4   
Gender           6.0  (0.01) 
  Male 338 55.8 380 62.7   
  Female 268 44.2 226 37.3   
SES Index           49.3  (<0.001) 
  Q1  (Low) 180 29.7 109 
18   
  Q2  (Mid-Low) 170 28.1 150 
24.8   
  Q3  (Mid-High) 153 25.6 148 
24.4   
  Q4  (High) 103 17 199 
32.8   
Ethnicity           47.5  (<0.001) 
  Brahmin 117 19.3 153 25.3   
  Chettri 124 20.5 104 17.2   
  Rai 20 3.3 14 2.3   
  Madishe 61 10.1 78 12.9   
  Limbu 17 2.8 4 0.7   
  Magar 105 17.3 45 7.4   
  Tharu 21 3.5 28 4.6   
  Other 141 23.3 180 29.7   
Fuel Use           3.2  (0.52) 
  Modern Fuel  42 6.9 48 7.9   
  Wood Only 555 91.6 541 89.3   
  Coal Only 4 0.7 6 1   
  Biomass Only  4 0.7 9 1.5   








        
56.6  (<0.001) 
  Bagmati 9 1.5 9 1.5   
  Bheri 36 6.1 24 4   
  Dhaulagiri 25 4.2 17 2.9   
  Gandaki 91 15.3 55 9.2   
  Janakpur 33 5.6 40 6.7   
  Karnali 11 1.9 4 0.7   
  Koshi 59 9.9 50 8.4   
  Lumbini 116 19.5 114 19.1   
  Mahakali 13 2.2 14 2.4   
  Mechi 24 4 24 4   
  Narayani 72 12.1 162 27.2   
  Rapti 45 7.6 38 6.4   
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Table 4: Product Specific Odds Ratios by Ethnicity 
 
Overall Brahmin Chettri 
CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI 
Non smokers 59/244 1 - 12/65 1 - 9/35 1 - 
Choor/Kankat 113/39 10.2 6.2-16.6 17/9 13.5 5.8-31.2 29/11 9.8 2.9-25.5 
Bidi 111/74 5.6 3.6-8.7 11/14 8.7 3.9-19.8 18/11 5.9 2.4-14.2 
Filtered Cigarettes 74/89 3.4 2.2-5.3 20/26 3.7 1.7-8.1 17/11 2.5 1.1-5.7 
Unfiltered Cigarettes 245/157 4.9 3.4-7.2 55/39 6.7 3.2-14.1 51/35 4.3 1.9-9.9 
             
 Madishe/Tharu Rai/Limbu/Magar/Other     
 CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI     
Non smokers 10/52 1 - 28/92 1 -     
Choor/Kankat 12/4 16.4 6.5-41.4 55/15 8.1 4.3-15.4     
Bidi 39/19 8.6 3.7-20.1 43/30 4.6 2.6-8.3     
Filtered Cigarettes 9/15 3.8 1.7-8.6 28/37 2.2 1.2-3.9     
Unfiltered Cigarettes 11/15 5.4 2.5-11.7 128/67 3.8 2.2-6.4     








Table 5: Number of Tobacco Products Used and Lung Cancer Risk by Ethnicity 
# of Products 
Used 
Overall Brahmin Chettri 
 CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI 
0 59/244 1 - 12/65 1 - 9/35 1 - 
1 302/231 4.2 2.9-6.1 55/54 6 2.9-12.6 63/38 3.9 1.7-9 
2 150/84 6.3 4.1-9.6 36/21 9.9 4.5-22.1 20/19 6.9 2.9-16.6 
3+ 96/47 7 4.3-11.4 16/12 13.5 5.5-33.6 33/11 10.5 3.8-28.5 
          
# of Products 
Used 
Madishe/Tharu Rai/Limbu/Magar/Other 
   
 CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI 
0 10/52 1 - 28/92 1 - 
1 39/36 4.8 2.0-11.5 145/103 3.4 2.0-5.8 
2 22/12 9.2 3.2-26.3 72/32 5.5 2.9-10.5 
3+ 8/15 5.9 1.6-21.9 39/17 5.1 2.3-11.0 







Table 6: Tobacco Pack Years and Lung Cancer Risk by Ethnicity 
  Overall Brahmin Chettri 
  CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI 
0  (Non Smokers) 59/244 1 - 12/65.0 1 - 9/35.0 1   
1-15.0 175/210 3.165 2.2-4.6 27/45 5.1 2.4-10.8 39/33.0 3.4 1.4-7.8 
15.01 - 30 150/79 8.8 5.5-14.4 23/18 10.5 4.5-24.1 29/19.0 7.5 3.0-19.2 
30 + 223/73 16.2 9.7-27.2 57/24 23.7 9.5-59.2 48/16.0 17.4 6.4-47.3 
p  trend <0.001  p  trend <0.001  p  trend <0.001 
          
 Madishe/Tharu Rai/Limbu/Magar/Other    
 CS/CNt OR* 95 % CI CS/CNt OR* 95 % CI    
0  (Non Smokers) 10/52.0 1 - 28/92.0 1 -    
1-15.0 27/37 3.4 1.4-8.4 82/95 2.5 1.4-4.3    
15.01 - 30 17/11.0 8.9 2.9-26.9 81/31 6.2 3.2-11.9    
30 + 25/7.0 19.9 6.0-66.0 93/26 9.1 4.7-17.9    
     p  trend <0.001  p  trend <0.001    






Chapter 4:  Urinary Metabolites of 1,3-Butadiene as a Biomarkers of CRHAP Exposure 
from Combustion of Biomass Fuels – Findings from Nepal 
 
Abstract 
INTRODUCTION: Nearly half the global population relies on biomass cooking fuels. Exposure to combustion related 
household air pollution (CRHAP) resulting from combustion of such biomass fuels has been attributed to nearly 4 
million deaths each year globally. Ongoing epidemiological studies have suffered from lack of robust exposure metric 
that captures the miscellany of CRHAP exposure including type of fuels used, presence/absence of separate kitchen, 
ventilation, and time activity pattern. Expert panels convened by the National Institute of Health offered several 
solutions, including use of urinary biomarker to capture overall exposure. Many urinary biomarkers have been 
investigated to estimate personal exposure levels, but a scientific consensus has not been reached.  In our study, we 
measured urinary metabolites of 1,3 butadiene in a heavily CRHAP exposed Nepali adult population.  
METHODS: We used control population from a previously completed lung cancer case-control study. Urine samples 
from 587 controls were analyzed for urinary metabolite of 1,3-butadiene (monohydroxybutyl mercapturic acid: 





MS/MS).  We used multivariate linear regression models to analyze the association between biomass fuel use and 
urinary MHBMA and DHBMA levels while controlling for known confounders including age, sex, SES, and smoking 
status.   
RESULTS: The mean MHBMA and DHBMA concentrations were 375.7 + 313.8 and 444.7 + 428.9 ng/mL 
respectively.  Mean concentrations of both metabolites were higher among biomass fuel users compared to modern fuel 
users.  Furthermore, we observed a significant association between urinary MHBMA and biomass fuel use status (p-
value = 0.006) while controlling for known confounders. We did not observe such association for DHBMA   
CONCLUSION:  Overall, our results indicate that urinary MHBMA is associated with biomass fuel usage, and can 
serve as a potential biomarker of recent exposure to biomass fuel use. 
Introduction 
Combustion related household air pollution (CRHAP) resulting from combustion of biomass fuel is of 
significant concern to public health (Lim et al., 2012; WHO, 2014).   Previous studies have  shown the negative health 
impacts of CRHAP exposure including increased respiratory infection, decreased lung function, asthma exacerbation, 





stress, impaired neurologic development in children, and  others (Barregard et al., 2008, 2006; Delfino et al., 2006; 
Hashibe et al., 2011; Irigaray et al., 2007; Josyula et al., 2015; Lim et al., 2012; Sapkota et al., 2013, 2008; Stockfelt et 
al., 2012).  Recent studies  have proposed that acute CRHAP exposure may have immunotoxic effects by impairing the 
pulmonary macrophages, effectively increasing infection rates and subsequent diseases (Naeher et al., 2005; Rylance et 
al., 2015).   
Epidemiological studies of focusing on CRHAP have suffered from a lack of suitable exposure metric as the 
traditional bulky air monitors are not an option in remote areas of the world where CRHAP exposure is the most 
prevalent. Such areas lack often lack roads and electricity necessary to operate such monitors. With this challenge in 
mind, the National Institute of Health convened a panel of expert to identify suitable exposure metric and set of 
pressing research questions related to CRHAP exposure from the combustion of biomass fuels (Gordon et al., 2014; 
Martin et al., 2013).  The expert panel recommended use of novel biomarker as one of the potential solution that can 
capture inter-individual variability in exposure resulting from types of fuels used, ventilation, presence of separate 
kitchen, time activity pattern, and cooking duration. As defined by the EPA, biomarkers are measureable substances or 





responses, or adverse health effects (EPA, 2012).  Various biomarkers and the associated metabolic pathways have 
been investigated to measure CRHAP exposure in different human media.  The most common method has been through 
urine samples due to the non-invasive nature of collection.  The research and need to identify an appropriate biomarker 
that can quickly and accurately quantify CRHAP exposure has been growing; however, no consensus has been reached 
in the scientific community on an appropriate urinary biomarker.  Numerous studies have investigated urinary 
levoglucosan, methoxyphenols, polycyclic aromatic hydrocarbon metabolites, and volatile organic compound 
metabolites as potential indicators of CRHAP exposure, which traditionally has focused on the use of wood stoves in 
the home for cooking and heating purposes in acute exposure settings (Bergauff et al., 2010; Boman et al., 2003; Clark 
et al., 2007; Dills et al., 2006, 2001; Hinwood et al., 2008; Mastral and Callén, 2000; Migliaccio et al., 2009; 
Sarigiannis et al., 2015).  These previous studies have yielded conflicting results into appropriate and effective urinary 
biomarkers of CRHAP exposure.  There has been no comprehensive evaluation of these biomarkers in high exposure 
residential settings which provides the greatest insight into urinary biomonitoring of CRHAP originating from biomass 
cooking fuels exposure.  Ideally, a biomarker of CRHAP should include the following characteristics: 1) It should be 





ambient exposure levels generate sufficiently high biomarker levels to be measured reproducibly; 3) the parent 
compound should be chemically stable in the environment, and the compound and it’s metabolites should be 
chemically stable in biological samples (Naeher et al., 2005).  Of the biomarkers investigated, metabolites of 1,3 
butadiene are of particular interest.     
International Agency for Research on Cancer (IARC) has identified 1,3 butadiene, a component of CRHAP, as 
a known human carcinogen, therefore quantifying individual level exposure to 1,3 butadiene among a highly exposed 
population may provide insights into mechanisms involving carcinogenicity of CRHAP exposures.   Monohydroxy-3-
butenyl mercapturic acid (MHBMA) and 1,2-dihydroxybutyl mercapturic acid (DHBMA) are two major metabolites of 
1,3 butadiene commonly measured in urine (Albertini et al., 2001; Boogaard et al., 2001; Fustinoni et al., 2004; Rogene 
F Henderson et al., 1996; Sapkota et al., 2006; Urban et al., 2003).  Difficulties arise when targeting 
MHBMA/DHBMA as 1,3 butadiene is part of automobile exhaust and is therefore ubiquitous in the ambient air, 
particularly in the urban environment.  Similar to other biomarkers, both metabolites are created from the combustion 
of organic material not specific to CRHAP.  Other sources of MHBMA/DHBMA include industrial processes, tobacco 





about the usefulness of MHBMA/DHBMA as indicators of CRHAP.  Much of the research has focused on 1,3 
butadiene exposures in occupational settings, which are not generalizable to the general population (Albertini et al., 
2001; Richard J Albertini et al., 2003; Boogaard et al., 2001; Fustinoni et al., 2004).  The main advantage of using 
MHBMA/DHBMA is the validated and established laboratory methods especially for urine sample analysis (Osterman-
Golkar and Bond, 1996; Sapkota et al., 2006; Schettgen et al., 2009; Urban et al., 2003).  Using metabolites of 1,3 
butadiene may not be appropriate in areas heavily influences by vehicle traffic and industrial sources; however, such 
metabolites may be useful in low and middle income agricultural populations.  Rural areas, especially in LMICs, are 
less impacted by vehicle traffic and industrial sources compared with large urban centers and these areas often rely 
heavily upon biomass cooking fuels.   
In this study, we investigated the urinary concentration of 1,3 butadiene metabolites among healthy Nepalese 
adults and the association to biomass cooking fuels.  Our findings will further the understanding of personal exposure 
to CRHAP originating from biomass cooking fuels across Nepal.  Results will provide an impetus for targeted 
interventions that can directly reduce harmful exposures and CRHAP related diseases in Nepal.  Furthermore, an 





research gap (Rylance et al., 2013; Simpson and Naeher, 2010).  The larger implications related to CRHAP may yield 
the greatest public health impact as this project can propel exposure research in other LMICs that rely heavily on 
biomass fuels as a primary heating and cooking fuel.                
 
Materials and Methods  
 Study Population 
A hospital-based case-control study was conducted at the B.P. Koirala Memorial Cancer Hospital (BPKMCH), 
located in the city of Bharatpur, Chitwan District, Nepal, from November 2009 through December 2012.  Located 150 
kilometers southwest of Kathmandu, BPKMCH is the major cancer hospital in Nepal.  The details regarding participant 
recruitment and biological sample collections have been described previously (Hashibe et al., 2011; Raspanti et al., 
2015).  In brief, 606 incident lung cancer cases and 606 age (+/- 5 years) and gender matched controls were recruited 
from the hospital after receiving informed consent.  To eliminate any effect of lung cancer, we limited our analysis to 





The control population was selected from various hospital visitors to frequency match the distribution of the 
lung cancer case population by age (+/-) 5 years, sex, ethnicity, and residence.  The controls were visitors at BPKMCH 
excluding, family members of participating lung cancer cases.  Prior to field implementation, standardized lifestyle and 
food frequency questionnaires were translated into Nepali language by native speakers and pilot tested in the field.  
Locally trained interviewers collected information on demographic characteristics, education, residential mobility 
throughout lifetime, type of cooking and heating fuel used at each residence, occupational history, and family history of 
cancer.  The study was approved by the Institutional Review Board at the University of Utah, University of Maryland 
as well as the Government of Nepal (Nepal Health Research Council).    
 
Urine Collection 
Each participant was given a unique identification number to correspond to biological samples and 
questionnaire data collected.  Biological samples were collected by trained hospital staff at BPKMCH.  Following 
recruitment and questionnaire administration, spot urine samples were collected from each participant.  The participants 





freezers until shipment to the University of Maryland.  The samples were shipped on dry ice and immediately stored in 
freezers upon receipt.   
 
Chemicals 
Isometric mixture of (R,S)-N-Acetyl-S-[1-(hydroxymethyl)-2-propen-1-yl)-L-cysteine and (R,S)-N-Acetyl-S-
[2-hydroxy-3-buten-1-yl)-L-cysteine (MHBMA), N-Acetyl-S-(3,4-dihyroxybutyl)-L-cysteine (DHBMA), and the 
deuterated analog (R,S)-N-Acetyl-S-[1-(hyrdoxymethyl)-2-propenyl)-L-cysteine-D6 (IS) were purchased from Toronto 
Research Chemicals, Ontario, Canada  (Catalog #A179005, #A173710, and #A179007 respectively).   
 
Sample Preparation 
Samples were stored in -80° C freezers until analysis.  The samples were thawed at room temperature prior to 
extraction.   Urine samples were extracted using a “dilute and shoot” approach.  Simply, 500 μL of acetonitrile was 





creating a final concentration of 400 ng/mL.  The samples were vortex-mixed and centrifuged for 10 minutes at 17,100 
g’s.  We removed 980 μL of supernatant leaving the precipitate undisturbed and injected 10 μL into the HPLC system.         
 
Sample Analysis 
Samples were analyzed with high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) 
using Shimadzu HPLC system coupled with an API3000 tandem MS/MS.  The total flow rate was 250 μL per minute 
with a constant binary mobile phase consisting of 80% acetonitrile and 20% HPLC-grade water with 0.1% ammonium 
hydroxide for a total run time of 2.5 minutes with a 40° C oven temperature.     
MHBMA, DHBMA, and MHBMA-d6 were detected in ESI negative mode.  MHBMA and DHBMA were 
detected using the MRM transition of m/z 232.2.3101.2 and m/z 250.1120.7 respectively.  Both compounds were 
quantified using MHBMA-d6 internal standard MRM transition m/z 238.1107.0.  A solvent based 12 point 
calibration curve was used for quantification (1000, 750, 500, 200, 100, 50, 10, 1, 0.5, 0.1, 0.01, and 0 ng/mL).  The 






Sample Recovery/Limit of Detection 
Recovery tests were conducted using 500 μL human urine samples spiked with MHBMA, DHBMA, and 
internal standard and extracted as above.  A 5 x 1 mL aliquots were spiked with 20 μL of 10 μg/mL working stock and 
10 μL of 10 μg/mL internal standard (400 ng/mL of MHBMA and DHBMA; 200 ng/mL IS) and extracted as 
previously described.  We divided the calculated metabolite concentration by the known spiked concentration to create 
a percentage of recovery.   
To determine limit of detection (LOD), we spiked 7 non-study participant human urine samples with 5 μL of 1 
μg/mL working stock and 10 μL of 10 μg/mL internal standard (100 ng/mL of MHBMA and DHBMA; 200 μg/mL IS).  
These samples were run as unknowns and quantified using calibration curve.  We calculated standard deviation of the 7 
samples and multiplied the standard deviation of the estimated concentrations by the Student’s t-test critical value at 
99% with 6 degrees of freedom to calculate the limit of detection (LOD).  Concentrations below the LOD were 
assigned values designated as LOD / square root of 2 as described previously (Finkelstein and Verma, 2001; Hornung 







Quality Control/Quality Assurance 
 QA/QC samples were included in each batch to monitor analytical accuracy of the instrument.  We included a 
double blank, spiked mobile phase, and a spiked urine sample.  Coefficient of variation (CV) was calculated for each 
metabolite, which is a commonly used evaluation of inter-batch accuracy.   
 
Statistical Analysis 
 All statistical analysis was performed using SAS 9.4 (Cary, NC).  We checked MHBMA and DHBMA for 
normal distribution using Kolmogorov-Smirnov goodness-of-fit test.  To test for difference in mean metabolite 
concentrations by fuel type and smoking status, we used Student’s t-test as appropriate.  We used chi-square tests to 
investigate correlation between potential categorical confounding variables to include in regression models in order to 
reduce multicollinearity and ensure a parsimonious model.  To investigate the impact of residential biomass cooking 
fuel use on observed urinary MHBMA and DHBMA concentrations, we created multiple linear regression models 





common confounding variables including age, gender, ethnicity, SES (Low, Mid-Low, Mid-High, and High), tobacco 
use (current, former, and non-smokers), and secondhand smoke exposure (SHS; yes/no).  We analyzed potential 
confounders for collinearity to reduce effects of highly correlated confounding variables included simultaneously in the 
model.  As our targeted metabolites are transient in nature, we focused on the most recent reported residence for fuel 
type.      
To minimize the impact of tobacco smoking, we stratified our analysis by self-reported tobacco use and 
reported results separately.  We investigated all reported methods of cooking (boiling, shallow frying, deep frying, and 
steaming) by adding them individually into the model to test significance, overall model fit, and influence on regression 
coefficients.  In addition, we investigated cooking behavior effect modification of the exposure-metabolite association 
by including interaction terms into the regression models.           
 
Results 
 A total of 606 participants were included in this study.  Of the 606 participants, 19 participants lacked urine 





participants reported using biomass fuels in their current residence.  The majority of our study population consisted of 
participants between the ages of 50-59 (38.12%) and males made up 62.71% of the study population.  The vast majority 
of the participants reported living in a rural area (86.14%) and in the mid-low SES group (36.6%).   Not surprisingly, 
the majority of participants reported being a current or former tobacco smoker (59.74%).   
 We recovered approximately 123% of MHBMA and 163% of DHBMA using spiked urine samples which were 
included in all sample batches.   We adjusted the calculated concentrations for recovery rates and the distribution 
statistics can be found in Table 8.  We observed a mean MHBMA concentration of 375.7 + 313.8.6 ng/mL and a mean 
DHBMA concentration of 444.7 + 428.9 ng/mL.  We observed a maximum MHBMA concentration of 1528 ng/mL and 
a maximum DHBMA concentration of 2773 ng/mL.  As expected, we observed higher mean and median 
concentrations of both biomarkers among biomass fuel users compared to modern fuel users as well as higher 
concentrations among smokers compared to non-smokers.  Specifically, we observed a statistically significantly higher 
mean MHBMA concentration among biomass fuel users compared to modern fuel users (p-value = 0.05).  
Furthermore, wood users had a significantly higher mean MHBMA concentration compared to modern fuel users (p-





  We created multivariate linear regression models to investigate the relationship between fuel use and 
metabolite concentrations as reported in Table 9.  After controlling for known confounders, we observed a significant 
increase in MHBMA concentrations with biomass fuel use [exp(β)=1.16; p-value=0.006] as well as wood use 
[exp(β)=1.19; p-value=0.002].  More specifically, biomass fuel use at home increased urinary MHBMA concentrations 
by 16% and wood use at home increased MHBMA concentration by 19%.  For DHBMA concentrations, we did not 
observe any significant associations between fuel use and observed metabolite concentrations.  Furthermore, we did not 
observe any significant associations between either metabolite concentrations and tobacco use, SES status or gender. 
  
  To reduce the impact of tobacco smoking further, we stratified our analysis by whether the participant reported 
using smoking tobacco (Table 10).  We created models for each fuel category individually.  Across never smokers and 
ever smokers, we observed increased concentrations of MHBMA with increased wood use compared to modern fuel 
users (16% and 23% respectively).  Similarly, overall biomass fuel users had a 15% increase in MHBMA 
concentrations compared to modern fuel users among ever smokers with borderline significance.  When stratified by 





only users compared to modern fuel users among shallow frying groups.  As expected, higher metabolite levels were 
observed among the participants who smoke than the non-smokers, but our results suggest that using biomass cooking 
fuels can increase personal exposure to 1,3 butadiene, which is a known human carcinogen, independently from 
tobacco use (Edward et al., 2014; IARC, 2010a, 2006).   
  
Discussion 
 Recent studies have identified improved exposure assessment tools to measure personal exposures to CRHAP 
resulting from biomass cooking fuels as an important environmental health priority (Hosgood et al., 2014; Lim et al., 
2012; Rylance et al., 2013).  With nearly half the global population using biomass cooking fuels, the need to 
understand personal exposure and resulting health effects is critical (WHO, 2014).  CRHAP from biomass cooking 
fuels is a complex mixture of particles and pollutants, including known human carcinogens such as 1,3 butadiene (EPA, 
2007; IARC, 2006; Noonan et al., 2012; Ward et al., 2008; Zhang and Smith, 1996).  Measuring the two primary 
urinary metabolites of 1,3 butadiene, MHBMA and DHBMA in urine, has been used in other settings to estimate 





(Albertini et al., 2001; Boogaard et al., 2001; Fustinoni et al., 2004; Sapkota et al., 2006; Smith et al., 2001).  To the 
best of our knowledge, this study is the first of its kind to target urinary MHBMA and DHBMA as biomarkers of 
exposure to CRHAP from biomass cooking fuels in a highly exposed population in Nepal. 
 While our results are unique, the concentrations of urinary MHBMA and DHBMA are comparable to studies in 
other populations and settings.  A noted study among a Czech rubber manufacturing plant reported mean post-exposure 
urinary MHBMA and DHBMA concentrations among the highest exposed group of 120.7 ng/mL and 4647 ng/mL 
respectively, while our reported mean concentrations of both MHBMA and DHBMA are 375.7 ng/mL and 444.7 
ng/mL in the total study population (Albertini et al., 2001; Richard J Albertini et al., 2003).  Interestingly, our reported 
mean MHBMA is nearly 3 times the concentration reported among the highest exposed Czech workers and our 
DHBMA is nearly 10 times lower than the highest exposed Czech workers.  Prior to our analysis, we did expect our 
observed concentrations to be higher than previous studies due to the intense and widespread exposures in our study 
population.  Similarly, our study population consisted of many smokers and those exposed to SHS.  Difficulties arise 
when comparing exposures across different populations and environments, but we are confident that our results reflect 





 Most importantly, our results highlight MHBMA as a strong candidate to be used as a biomarker of CRHAP 
exposure from biomass cooking fuels.  Our results show that MHBMA concentrations are significantly higher among 
overall biomass fuel users, as well as wood users, after controlling for many known demographic and socioeconomic 
factors.  Furthermore, the significant increases among never smokers show the true contributions of CRHAP to urinary 
biomarker concentration independent from tobacco use.  Previously, IARC has classified wood/biomass use as a 
potential human carcinogen; however, our results show that biomass fuel exposure does in fact significantly increase 
personal exposure to known human carcinogens, but the final link to carcinogenesis remains unclear.         
Only 8% of our participants reported deep frying as a cooking method for fish, meats, and/or vegetables 
compared with 98% who reported shallow frying.  We did not observe any noted associations between urinary 
metabolite levels and boiling or steaming cooking methods which adds further confidence to our results.  All fuel and 
cooking method interaction terms were not significant and removed from the final analysis.  Participants were not 
asked the frequency or preference of cooking method, rather if they used the method for meats, fish, or vegetables.           
 In this study, we aimed to quantify urinary biomarkers MHBMA and DHBMA to investigate their association 





regression models controlling for known confounders such as age, ethnicity, gender, tobacco use, SHS exposure, SES, 
and cooking methods.  We investigated numerous potential confounding variables by adding them individually to the 
model and comparing model fit statistics.  In all, we decided to remove variables reflecting ventilation, urban/rural 
status, presence of a separate kitchen, and self-reported level of smokiness during cooking as these variables were 
highly correlated to cooking fuel type and/or SES.  Our decision to remove these variables from the final analysis is 
reflective of our desire to retain parsimony and reduce any influence of multicollinearity within our analysis.     
 The diverse and large study population is a major strength of this study.  Secondly, we used well validated 
HPLC-MS/MS analytical methods for MHBMA and DHBMA metabolite detection and quantification.  Also, we were 
able to control for many known confounding effects that could influence our observed metabolite concentration.  
Namely, we had robust measures of tobacco use, frequency, and type of products smoked to allow us to control for 
these effects confidently.  Similarly, we were able to include individual cooking methods and interactive effects of 
cooking methods and fuel type.  While this study had numerous strengths, we also encountered limitations.  While 
biomarkers are identified as “gold standards” in exposure assessments, it is extremely difficult to identify source 





very difficult to isolate exposures from biomass cooking fuels only.  We controlled and stratified our analysis to 
remove the effects of many known confounding variables to the best of our ability.  We did not normalize for urinary 
creatinine levels.  In the future, we will perform additional analysis for urinary cotinine and levoglucosan to better 
characterize CRHAP exposure in this population.    
 In conclusion, we observed significant associations between urinary MHBMA and individual level CRHAP 
exposure from biomass cooking fuels.  These results can be directly applied to invention-based cook stoves studies to 
reduce the burden of disease associated with CRHAP and biomass cooking fuels.  While our results are promising, 
further research is needed into MHBMA, DHBMA, and other potential urinary biomarkers of exposure in other 



























Manuscript 2 Tables: 
 
Table 7: Demographic Characteristics 
    N % 
Fuel Type    
 Modern Fuel 141 23.27 
 Biomass Fuel 465 76.73 
 Wood Only 437 72.11 
  Biomass Only 28 4.62 
 Age    
 <40 24 3.96 
 40-49 121 19.97 
 50-59 231 38.12 
 60-69 179 29.54 
  70 + 51 8.42 





 Male 380 62.71 
  Female 226 37.29 
Ethnicity    
 Brahmin 153 25.25 
 Chettri 104 17.16 
 Rai/Limbu/Magar/Other 243 40.10 
 Madishe/Tharu 106 17.49 
SES Index      
 Low 150 24.75 
 Mid-Low 222 36.63 
 Mid-High 109 17.99 
  High 125 20.63 
Tobacco Use   
 Non-Smoker 244 40.26 
 Ever Smoker 362 59.74 
Urban/Rural Status    
 Urban 84 13.86 
  Rural 522 86.14 
Secondhand Smoke Exposure     
 No  456 75.25 












Table 8: Distribution Statistics  





N Mean SD Median  Range 
p-
valuea 
 Mean SD Median  Range 
p-
valuea 








141 349.9 315.8 248.8  
<LOD-
1528 







465 383.6 313.1 271.5  
<LOD-
1496 







28 274.6 234.4 207.3  
<LOD-
984 







437 390.8 316.6 282.1  
<LOD-
1496 








244 376.8 323 255.3  
<LOD-
1439 







362 375 307.8 265  
<LOD-
1528 
















Table 9: Selected Linear Regression Results - Only Current Residence 
 Label N 
MHBMAa   DHBMAa 
β exp(β)b % Change p-value   β exp(β)b % Change p-value 
Current Fuel Use Modern 141 REF REF REF REF  REF REF REF REF 
 Wood 437 0.17 1.19 19 0.002  0.08 1.09 9 0.18 
 Biomass 28 0.01 1.01 1 0.96  -0.11 0.90 -10 0.4 
  Wood+Biomass 465 0.15 1.16 16 0.006   0.06 1.06 6 0.3 
Tobacco Use 
Never 244 REF REF REF REF  REF REF REF REF 
Ever 362 0.03 1.03 3 0.5   0.01 1.01 1.00 0.77 
SES 
Low 146 REF REF REF REF  REF REF REF REF 
Mid-Low 226 -0.11 0.90 -10 0.12  -0.09 0.91 -9 0.27 
Mid-High 109 -0.10 0.90 -10 0.25  -0.11 0.90 -10 0.21 
High 127 -0.07 0.93 -7 0.4   -0.06 0.94 -6 0.51 
Gender 
Female 226 REF REF REF REF  REF REF REF REF 
Male 382 -0.01 0.99 -1 0.9   0.02 1.02 2 0.74 
SHS  
No 458 REF REF REF REF  REF REF REF REF 
Yes 148 -0.13 0.88 -12 0.01   -0.15 0.86 -14 0.01 
Deep Fry Meat/Fish/Vegetables 
No  556 REF REF REF REF  REF REF REF REF 
Yes 50 -0.25 0.78 -22 0.002   -0.32 0.73 -27 0.0002 
Shallow Fry 
Meat/Fish/Vegetables 
No  15 REF REF REF REF  REF REF REF REF 
Yes 591 0.25 1.28 28 0.07   0.28 1.32 32 0.07 
a=MHBMA/DHBMA concentrations are log transformed and results presented have been exponentiated;            











Table 10: Stratified Analysis a 
  N 
  MHBMA     DHBMA 
β exp(βa) % Change p-value   β exp(βa) % Change p-value 
Overall                   
Modern 141 REF REF REF REF  REF REF REF REF 
Wood Only 437 0.17 1.19 19 0.002  0.08 1.09 9 0.18 
Biomass Only 28 0.01 1.01 1.00 0.96  -0.11 0.90 -10 0.4 
Wood+Biomass 465 0.15 1.16 16 0.006   0.06 1.06 6 0.3 
Smoking Status 
Never Smoker                    
Modern 72 REF REF REF REF  REF REF REF REF 
Wood Only 163 0.15 1.16 16 0.04  0.09 1.10 10 0.2 
Biomass Only 9 0.03 1.03 3 0.87  -0.21 0.81 -19 0.33 
Wood+Biomass 172 0.16 1.17 17 0.07   0.08 1.09 9 0.36 
Ever Smoker                    
Modern 69 REF REF REF REF  REF REF REF REF 
Wood Only 274 0.21 1.23 23 0.002  0.09 1.09 9 0.24 
Biomass Only 19 0.03 1.03 3 0.83  0.01 1.01 1 0.97 
Wood+Biomass 293 0.14 1.15 15 0.05   0.03 1.03 3 0.71 
Cooking Methodb 
Deep Fry                     
Modern 13 REF REF REF REF  REF REF REF REF 
Wood Only 33 -0.07 0.94 -6 0.6  -0.23 0.79 -21 0.07 
Biomass Only 4 0.06 1.06 6 0.84  0.78 2.17 117 0.81 
Wood+Biomass 37 0.03 1.03 3 0.87   0.00 1.00 0 0.99 
Shallow Fry                     
Modern 136 REF REF REF REF  REF REF REF REF 
Wood Only 428 0.19 1.21 21 0.001  0.10 1.10 10 0.12 
Biomass Only 27 0.02 1.02 2 0.88  -0.09 0.92 -8 0.51 
Wood+Biomass 455 0.16 1.17 17 0.004  0.07 1.07 7 0.27 
a=MHBMA and DHBMA coefficients have been exponentiated; 





Chapter 5: Urinary Biomarkers of CRHAP Exposure from 




In this chapter, we investigated the relationship between urinary 
metabolites of 1,3 butadiene and lung cancer etiology in a highly exposed 
population in Nepal.  We utilized the data previous collected from the urine 
sample analysis and the questionnaire based data to create logistic regression 
models to estimate the association between observed urinary MHBMA and 
DHBMA concentrations as measures of personal-level exposure and lung cancer 
risk.  As much of the methods and background material is presented in previous 





 A total of 606 confirmed lung cancer case and 606 frequency matched on 
age, gender, and geographical residence controls were included in this analysis.  
Overall, the majority of our lung cancer cases were male (55.78%), between the 
ages of 60-69 (41.42%), and in the lowest SES group (35.80%).  Not surprisingly, 
nearly 90% of lung cancer cases reported tobacco smoking while only 59.7% of 
controls reported tobacco smoking (Table 11).  We observed significant chi-





cook stove ventilation, presence of a separate kitchen, and physician diagnoses 
tuberculosis (all p-values < 0.05).  Interestingly, we observed a significant chi-
square results for DHBMA quartiles (p-value = 0.02), but not for MHBMA 
quartiles (p-value =0.08).   
 The results of the logistic regression models can be found in Table 12.  
We did not observe any significant association between the log-transformed 
metabolite concentrations and lung cancer risk when controlling for known 
confounding variables.  As expected, we observed significant associations 
between lung cancer risk and tobacco use (OR 5.64; 95% CI 3.80-7.59), age (OR 
1.03; 95% CI 1.02-1.04), and females (OR 1.94; 95% CI 1.47-2.57).    
 To better control of the effects of tobacco, we stratified our analysis by 
smoking status in Table 13.  Overall, we did not observe any considerable 
association between observed metabolite concentrations and lung cancer risk.  
Although, we did borderline significant association between increasing MHBMA 
concentration and lung cancer risk among the total population; however, this 
relationship remains unclear.   
Discussion 
 Overall, our analysis did not provide evidence of an association between 
1,3 butadiene measured through urinary biomarkers and lung cancer risk.  We feel 
this is due to the very transient nature of biomarkers of exposure.  In most cases, 





environmental chemicals and the applicability of biomarkers of exposure at 
estimating long term, repeated exposures is limited.  As useful as biomarkers of 
exposure are for measuring overall personal exposure to particular environmental 
chemicals, difficulties arise when focusing on a specific source of the pollution.  
In our analysis, we aimed to estimate personal exposure to CRHAP derived from 
biomass cooking fuels as measured by metabolites of 1,3 butadiene.  While 
controlling for known contributions of personal 1,3 butadiene exposure from 
other non-biomass fuel sources, we were unable to uncover any conclusive 
statistical associations.  
  
 In conclusion, our analysis and results do not support our primary 
hypothesis that urinary 1,3 butadiene metabolite concentrations are significantly 
and directly associated with increased lung cancer risk among a highly exposure 
Nepali population.  It is our interpretation that the highly transient nature of the 
1,3 butadiene metabolites are useful for short term, recent exposure, but not useful 











Manuscript 3 Tables 
Table 11: Demographic characteristics of the study population 
  Lung Cancer Cases Controls   




     6.69 (0.08) 
 Q1  176 29.04 165 27.23  
 Q2 135 22.28 156 25.74  
 Q3 161 26.57 130 21.45  




     10.05 (0.02) 
 Q1  158 26.07 185 30.53  
 Q2  134 22.11 156 25.74  
 Q3  166 27.39 124 20.46  
  Q4  148 24.42 141 23.27   
 Age      
98.49 
(<0.0001) 
 <40 27 4.46 24 3.96  
 40-49 45 7.43 121 19.97  
 50-59 152 25.08 231 38.12  
 60-69 251 41.42 179 29.54  
  70 + 131 21.62 51 8.42   
Gender      6.03 (0.01) 
 Male 338 55.78 380 62.71  
  Female 268 44.22 226 37.29   
Ethnicity      
47.48 
(<0.0001) 
 Brahmin 117 19.31 153 25.25  
 Chettri 124 20.46 104 17.16  
 Rai 20 3.3 14 2.31  
 Madishe 61 10.07 78 12.87  
 Limbu 17 2.81 4 0.66  
 Magar 105 17.33 45 7.43  
 Tharu 21 3.47 28 4.62  
  Other 141 23.27 180 29.7   
SES Index in 
Quartiles 
     
20.24 
(0.0002) 
                                                    Low 217 35.8 150 24.8  
 Mid-Low 170 28.1 222 36.6  





  High 125 20.6 125 20.6   
Tobacco Use      
150.61 
(<0.0001) 
 Non-Smoker 59 9.7 244 40.3  
  Smoker 547 90.3 362 59.7   
Tobacco Packyears 
(PYs) in Quartiles 






175 28.9 210 34.7  
 Q3 (11.9-30 PYs) 150 24.8 79 13  
  Q4 (> 30 PYs) 223 36.8 73 12.1   
SHS No  432 71.3 456 75.3 2.42 (0.12) 
  Yes 174 28.7 150 24.7   




404 66.7 356 58.8   
Level of Smokiness Low 42 6.9 35 5.8 3.68 (0.29) 
 Mid-Low 90 14.9 108 17.8  
 Mid-High 166 27.4 146 24.1  
  High 308 50.8 317 52.3   
Separate Kitchen No 93 15.3 129 21.3 7.15 (0.008) 
  Yes 513 84.7 477 78.7   
TB Status Negative 518 85.5 562 92.7 
16.46 
(<0.0001) 
















Table 12: Odds Ratios (OR) and 95% Confidence Interval for Biomarker Concentration and 
selected confounders  
   
Cases (n) Controls (n) ORb 95% CI 
      
MHBMAa   606 606 0.94 0.84-1.06 
DHBMAa   606 606 1.05 0.94-1.16 
Smoking Status 
Never 59 244 1.00 - 
Ever 547 392 5.34 3.8-7.59 
Age   606 606 1.03 1.02-1.04 
Gender 
Male 338 380 1.00 - 
Female 268 226 1.94 1.47-2.57 
SES 
Low 217 150 1.00 - 
Mid-
Low 
170 222 0.56 0.40-0.79 
Mid-
High 
94 109 0.52 0.34-0.77 
High 125 125 0.65 0.45-0.94 
SHS Exposure 
No 432 456 1.00 - 
Yes 174 150 0.33 0.99-1.79 
a=Biomarker concentration (ng/mL) were log transformed 
















Ever Smokers   Never Smokers 
Case (n) Control (n) OR* 95 % CI   Case (n) Control (n) OR* 95 % CI   Case (n) Control (n) OR** 95 % CI 
MHBMA               
Q1 176 165 1 - 
 
158 95 1 - 
 
18 70 1 - 
Q2 135 156 0.69 0.48-1.0 
 
123 96 0.64 0.43-1.0 
 
12 60 0.85 0.36-1.98 
Q3 161 130 1.06 0.75-1.51 
 
147 84 0.97 0.65-1.46 
 
14 46 1.19 0.52-2.71 
Q4 134 155 0.72 0.51-1.03   119 87 0.71 0.47-1.07   15 68 0.69 0.30-1.54 
      p-trend 0.04       p-trend 0.08       p-trend 0.62 
DHBMA               
Q1 158 185 1 - 
 
140 109 1 - 
 
18 76 1 - 
Q2 134 156 0.95 0.67-1.35 
 
121 95 0.99 0.66-1.48 
 
13 61 0.98 0.43-2.24 
Q3 166 124 1.27 0.89-1.81 
 
155 76 1.37 0.91-2.06 
 
11 48 1.01 0.42-2.42 
Q4 148 141 1.02 0.72-1.46   131 82 1.05 0.70-1.59   17 59 0.96 0.43-2.13 
      p-trend 0.43       p-trend 0.4       p-trend 0.99 
* Adjusted for age, sex, ethnicity, SES, SHS, total pack years                                     







Chapter 6: Household Air Pollution and Lung Cancer Risk 
among Never-Smokers in Nepal 
Raspanti, G.A., Hashibe, M., Siwakoti, B., Wei, M., Kumar, B., Bahadur, C., Al-
temimi, M., Lee, Y.A., Sapkota, A., 2016. Household air pollution and lung 




More than half of the global population relies on biomass fuels (wood, charcoal, 
crop residue, dung) for cooking and/or heating purposes.  Combustion related 
household air pollution (CRHAP) resulting from the use of these biomass fuels is 
of particular concern, given the overall prevalence as well as the intensity of 
exposure and the range of potential adverse health outcomes.  Long term exposure 
to CRHAP is a major public health concern, particularly among women and 
children in low and middle income countries.  In this study, we investigated the 
association between exposure to CRHAP and lung cancer risk among Nepalese 
population.  Using a hospital-based case-control study (2009 - 2012), we recruited 
606 lung cancer cases and 606 healthy controls frequency matched on age (+/- 5 
years), gender, and geographical residence. We used unconditional logistic 
regression to compute odds ratios (ORs) and 95% Confidence Intervals (95% CI) 
for lung cancer risk associated with CRHAP exposures, adjusting for potential 





second hand smoke).  In our overall analysis, we observed increased risk of lung 
cancer among those who were exposed to CRHAPs (OR: 1.78, 95% CI: 1.01-
3.15). A more detailed analysis stratified by smoking status showed considerably 
higher risk of lung cancer associated with increasing duration of biomass specific 
CRHAP exposure, with evidence of an exposure-response relationship (Ptrend = 
0.05) that was more pronounced among never-smokers (Ptrend = 0.01). Our results 
suggest that chronic exposure to CRHAP resulting from biomass combustion is 




Combustion related household air pollution (CRHAP) resulting from 
incomplete combustion of biomass fuels (wood, coal, agricultural waste, charcoal, 
and animal dung) for cooking and/or heating is a major global public health 
concern (Lim et al., 2012).  Recent estimates suggest that 3.5 million deaths are 
attributable to CRHAP, while additional 500,000 deaths are attributed to outdoor 
air pollution originating from indoor source annually (Lim et al., 2012).  The vast 
majority of these deaths occur in low and middle income countries (LMIC) where 
a significant proportion of the population relies on biomass fuels for cooking 





2014).  CRHAP is a complex mixture of pollutants including particulate matter, 
sulfur oxides, nitrogen oxides, carbon monoxide, polycyclic aromatic 
hydrocarbons, formaldehyde, and dioxins, to name few (Ding et al., 2012; EPA, 
2007; Naeher et al., 2007; Pruneda-Álvarez et al., 2012; Ward et al., 2008).  An 
increasing body of literature has illustrated the role of CRHAP in disease etiology 
of both acute and chronic health outcomes with women and children in LMIC 
bearing disproportionate disease burden (Adetona et al., 2013; Guarnieri et al., 
2014; Lim et al., 2012; Naeher et al., 2007; Pokhrel et al., 2013; Pradhananga et 
al., 2009; Romieu et al., 2009; Smith et al., 2010, 2000; Smith-Sivertsen et al., 
2009; WHO, 2014, 2013).    
The carcinogenicity of CRHAP exposure was extensively evaluated by an 
expert panel convened by the International Agency for Research on Cancer in 
2006 (IARC, 2010).  The panel classified CRHAP from coal as a known human 
carcinogen (IARC Group 1), while CRHAP from biomass was classified as a 
possible human carcinogen (IARC Group 2A), citing lack of epidemiologic 
evidence (IARC, 2010).  Since then few new studies have investigated the 
carcinogenicity of CRHAP particularly from biomass combustion (Sapkota et al., 
2013, 2008) while others have conducted systematic review and meta-analysis of 
the literature (Bruce et al., 2015; Josyula et al., 2015; Martin et al., 2013).  
However, few studies have comprehensively investigated the risk of CRHAP 





75% of the population heavily relies on biomass for cooking (Ghimire et al., 
2011).   
Nepal is one of the poorest countries in the world with an estimated 24% 
of the nearly 30 million people living under $1 a day (WHO, 2009).  Lung cancer 
is the most common cancer in men and third most common in women in Nepal 
(IARC, 2012).  Compared with all cancers in Nepal, lung cancer accounts for 
13% of new cancer incidence and 15% of cancer related mortality (IARC, 2012).  
Although, tobacco use is decreasing in Nepal, lung cancer incidence continues to 
rise and is projected to double by the year 2035 (Ferlay et al., 2010; Ghimire et 
al., 2011; IARC, 2012; WHO, 2009).  In this study, we evaluate the role of 
CRHAP in lung cancer etiology in Nepal, one of the highest exposed areas 
globally.   
 
Materials and Methods 
A hospital-based case-control study was conducted at B.P. Koirala 
Memorial Cancer Hospital (BPKMCH), Chitwan District, Nepal, from November 
2009 through December 2012.  Located 150 kilometers southwest of Kathmandu, 
BPKMCH is the major cancer hospital in Nepal.  The details regarding participant 
recruitment and biological sample collections have been described previously 
(Hashibe et al., 2011; Raspanti et al., 2015).  In brief, 606 incident lung cancer 





recruited from the hospital.  The inclusion criteria for a lung cancer case were: 1) 
18 years of age or older 2) resident of Nepal for at least five years and 3) were 
admitted to BPKMCH.  The eligible cases were recruited as soon as possible 
following lung cancer diagnosis with a target interval of one day and a maximum 
interval of 4 weeks.  A trained medical staff member reviewed medical records to 
extract relevant diagnostic information, including the date and method of 
diagnosis, histological type, tumor location, stage, and grade.  Final diagnosis of 
lung cancer was confirmed with histological, cytological, or X-ray based 
evidence.   
The controls were visitors at BPKMCH excluding friends and family 
members of participating lung cancer cases, and were frequency matched by age, 
gender, and geographic residence.  Prior to field implementation, standardized 
lifestyle and food frequency questionnaires were translated into Nepali language 
by native speakers and pilot tested in the field (Hashibe et al., 2011).  Locally 
trained interviewers collected information on demographic characteristics, 
education, residential mobility throughout lifetime, type of cooking and heating 
fuel used at each residence, occupational history, and family history of cancer.  
The study was approved by the Institutional Review Board at the University of 
Utah, University of Maryland as well as the Government of Nepal (Nepal Health 






We computed a lifetime profile of exposure to CRHAP based on duration 
and type of biomass fuel used at each reported residence across the lifespan.  We 
defined biomass fuel as wood, charcoal, agricultural waste and dung while 
modern fuel is defined as electricity and natural gas. For this analysis, individuals 
that predominantly used kerosene (>50% of their lifetime) were excluded (n=7) 
because while kerosene is a modern fuel, recent studies show that it has 
considerable adverse health impact (Bates et al., 2013; Epstein et al., 2013; Lam 
et al., 2012; Pokhrel et al., 2010). A variable reflecting duration of CRHAP 
exposure was created for each fuel type.  These product specific variables were 
summed to generate total years of CRHAP exposures. We further categorized 
CRHAP exposure and fuel specific exposure into quartiles based on distribution 
of exposure among controls.  Linear trends were examined by including the 
quartile variables as continuous within the models.     
Tobacco user was defined as someone who smoked greater than 100 
cigarettes or similar tobacco product in their lifetime.  Furthermore, we calculated 
tobacco pack years based on the duration as well as frequency of each tobacco 
product smoked as described previously (Raspanti et al., 2015).  Exposure to 
secondhand smoke (SHS) was captured by participant’s indication of living or 
working with someone who actively smoked tobacco.  We computed 
socioeconomic status (SES) index based on level of education, household 





per room) (Ghosh and Ghosh, 2009; Sapkota et al., 2008).  This SES index 
reflects the contributions of multiple indicators and a high value on this index can 
be interpreted as high SES.  We categorized the SES index into quartiles which 
reflect low, mid-low, mid-high, and high categories.   
Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated 
using multivariate logistic regression models to investigate the relationship 
between CRHAP exposure and lung cancer risk. We included age, gender, 
ethnicity, geographical region, tobacco use status, SHS exposure, and SES index 
(in quartiles) as confounders in the model as these are known contributors to lung 
cancer (Di Cesare et al., 2013; Hashibe et al., 2011; Raspanti et al., 2015).  We 
included an interaction term between CRHAP exposure and gender to detect 
potential effect modification; however, this term was not significant and was 
removed from the final model.  We also investigated the influence of residential 
characteristics of the home such as ventilation and smokiness during cooking by 
including them in the statistical model because the physical structure is known to 
contribute to the concentration and dispersion of CRHAP related pollutants 
(Batterman et al., 2006; Pokhrel et al., 2005; Seow et al., 2015; Zuraimi and 
Tham, 2008).  Participants were asked what type of ventilation or smoke 
extraction was used during cooking in each residence.  Response options included 
window, chimney, or none.  Smokiness during cooking was determined by the 





cooking events.  Participants were given the following options: cooking indoors 
with little smoke, some smokiness caused by cooking, much smokiness caused by 
cooking although no enough to irritate eyes, and much smokiness caused by 
cooking and enough to irritate eyes.  Interaction terms were included in the model 
to examine any effect modification between ventilation and type of fuel used.  
Furthermore, we included physician diagnosed tuberculosis (TB) as a confounder 
in the model as prior studies have highlight the link between TB and lung cancer 
risk as well as biomass cooking fuels potential contribution to TB (Huang et al., 
2015; Lin et al., 2014; Pokhrel et al., 2010; Skowroński et al., 2015). 
 
Results 
The demographic characteristics of the study population are presented in 
Table 14. In general, cases and controls were similar in terms of ethnicity and 
family income. Lung cancer cases tended to be slightly older, male, and less 
educated. The prevalence of smoking, as expected, was considerably higher 
among cases (Table 14).   
As shown in Table 15, the association between CRHAP exposure and lung 
cancer risk was statistically significant based on the overall analysis (OR 1.78; 
95% CI 1.03-3.15).   Furthermore, we observed significant increased lung cancer 





CI: 1.01-1.04), and females (OR 2.07; 95% CI 1.58-2.72).  Participants who had 
prior physician diagnosed TB had a considerably higher lung cancer risk 
compared to those who did not (OR 2.25; 95% CI 1.47-3.44). We also observed 
significant decreased lung cancer risk among those with higher SES status. We 
did not observe a significant association between lung cancer and presence of a 
separate kitchen, ventilation, or self-reported smokiness level during cooking and 
these variables were not included in the final model. Similarly, we did not observe 
a significant association between lung cancer risk and fuel, ventilation, and 
smokiness level interaction terms and were therefore removed from the final 
model.  Lastly, participants who reported living or working with a smoker had a 
higher risk of lung cancer compared to those who did not (OR 1.37; 95% CI 1.02-
1.84).   
Results for duration of CRHAP exposure from biomass fuel use and lung 
cancer risk, stratified by smoking status is depicted in Table 16. Here, we focused 
solely on biomass as CRHAP exposure from combustion of coal has been 
classified as IARC Group 1 carcinogen (IARC, 2010).  In the overall analysis, we 
observed evidence of an association between increased duration of CRHAP 
exposure and lung cancer risk (OR 1.71, 95% CI: 1.07-2.74 for 4th vs 1st quartile 
of exposure, Ptrend =0.05). Upon stratification, we observed an exposure-response 
relationship between increasing duration of exposure to CRHAP and lung cancer 





quartile of CRHAP exposure had considerably higher risk of lung cancer 
compared to those at the lowest quartile (OR 10.26; 95% CI 2.47-42.68). Among 
ever smokers, increased duration of CRHAP exposure was not associated with 
increased risk of lung cancer (Ptrend = 0.6).  
 
Discussion 
CRHAP originating from the combustion of biomass fuels contains many harmful 
pollutants including known human carcinogens (IARC, 2010), and is a major 
contributor to the global burden of disease (Lim et al., 2012; WHO, 2014).  Most 
recent IARC monograph has classified exposures to CRHAP from biomass 
combustion as probable human carcinogen (IARC, 2010), while subsequent 
comprehensive review and meta-analysis has linked exposures to CRHAP from 
biomass with lung cancer risk (Bruce et al., 2015). Our findings build upon this 
literature by documenting increased risk of lung cancer associated with exposure 
to CRHAPs from biomass among never-smoking Himalayan population.     
Approximately 71% of Nepali households cook inside the main living 
space, while 20% cook in a separate building and 8% cook outside (Ghimire et 
al., 2011) emphasizing the need to better understand the relationship between 
CRHAP from biomass cooking fuels and health in this region.  In our study, 





similar to studies conducted in India and elsewhere (Gupta et al., 2001; Perez-
Padilla et al., 2010; Sapkota et al., 2013).  Our findings regarding increased lung 
cancer risk among females, low SES, tobacco users, and exposure to SHS are in 
line with our hypothesis and previous literature (Binu et al., 2007; Pradhananga et 
al., 2009).          
Since tobacco consumption is a major risk factor for lung cancer, and 
residual confounding by smoking cannot be ruled out even when adjusting for it 
as a confounder, we stratified our analysis by ever and never smokers. This 
allowed us to investigate the lung cancer risk associated with CRHAP exposure, 
independent of tobacco smoking. We further restricted this analysis to participants 
with no co-exposure to coal.  In doing so, we observed an exposure-response 
relationship for duration of CRHAP exposure and lung cancer risk among never 
smokers (Ptrend = 0.01).  This increase in odds of lung cancer risk is similar to 
what has been reported in a study conducted in neighboring India (Sapkota et al., 
2008).  Conversely, we did not observe any significant association between lung 
cancer risk and CRHAP exposure among ever smokers, even after adjusting for 
tobacco pack years. A potential explanation for this is the strength of association 
between tobacco smoking and lung cancer is considerably higher by comparison, 
so an incremental increase in lung cancer risk associated with CRHAP exposure 





 Building characteristics, such as ventilation and smokiness during 
cooking activities are important factors to consider when estimating personal 
CRHAP exposure. Previous studies in China, Guatemala, Nepal, and Papua New 
Guinea have highlighted the potential benefits of properly ventilated cook stoves 
(Hu et al., 2014; McCracken et al., 2007; Smith et al., 2011, 2010; Smith-
Sivertsen et al., 2009; Tielsch et al., 2014; Werry, 2005; Zhang and Smith, 2007).  
In our study, we did not observe a statistically significant association between 
either ventilation or smokiness during cooking to lung cancer risk.  Lastly, we 
investigated urban versus rural residency as a potential confounding variable; 
however, this variable was highly correlated to our SES variable and we decided 
not to include the urban/rural classification to reduce multicollinearity.           
 There are several strengths of this study, including large diverse study 
population.  Participants were recruited from every geographic regions of Nepal.  
The study population is among the highest exposed population in the world.  This 
study is unique as it is one of the first to investigate the contribution of CRHAP 
exposure to lung cancer risk in Nepalese adults.  A limitation of this study is the 
self-reported nature of key variables, which are prone to recall bias.  However, the 
link between CRHAP exposure and lung cancer is relatively new, and as such our 
study participant’s responses regarding their past biomass fuel use were not likely 
influenced by it. Large variability exists in personal CRHAP exposures even if 





example, physical household characteristics such as presence/absence of 
ventilation, wall and roof structure, and size of the room may determine the true 
concentration and pollutant within homes. In addition, the time activity pattern, 
cooking frequency as well as time spent cooking each meal may determine 
individual’s true exposures. These detailed variables were not part of our data 
collection, and could not be accounted for in our statistical analysis.  Similarly, 
population density and outdoor-to-indoor infiltration also can contribute to 
CRHAP and related personal exposures.  The vast majority of our study 
population reported using wood which limited our ability to compare different 
types of fuel.   
   
 
Conclusion 
In summary, this study aimed to estimate lung cancer risk associated with 
CRHAP exposures in Nepal.  Our findings suggest that long term exposure to 
CRHAP from biomass is associated with increased lung cancer risks among never 
smokers. Public health strategies focused in mitigating cancer burden need to 
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Controls   
    N % N % Χ² (p-value) 
CRHAP Exposure in 
Quartiles 
     
37.62 
(<0.0001) 
 Q1 (0-46 years) 242 39.9 271 44.7  
 Q2 (46-56 years) 103 17 152 25.1  
 Q3 (56-65 years) 104 17.2 105 17.3  
  Q4 (> 65 years) 157 25.9 78 12.9   
Fuel Type      4.67 (0.32) 
 Modern Fuel 30 5.0 40 23.3  
   Natural Gas 30 5.0 40 23.3  
 Biomass Fuel 576 95.0 566 93.4  
 Wood 563 92.7 548 90.4  
 Coal 5 0.8 5 0.8  
 Biomass 4 0.7 10 1.7  
  Kerosene 4 0.7 3 0.5   
 Age      
98.49 
(<0.0001) 
 <40 27 4.46 24 3.96  
 40-49 45 7.43 121 19.97  
 50-59 152 25.08 231 38.12  
 60-69 251 41.42 179 29.54  
  70 + 131 21.62 51 8.42   
Gender      6.03 (0.01) 
 Male 338 55.78 380 62.71  
  Female 268 44.22 226 37.29   
Ethnicity      
47.48 
(<0.0001) 
 Brahmin 117 19.31 153 25.25  
 Chettri 124 20.46 104 17.16  
 Rai 20 3.3 14 2.31  
 Madishe 61 10.07 78 12.87  
 Limbu 17 2.81 4 0.66  
 Magar 105 17.33 45 7.43  
 Tharu 21 3.47 28 4.62  
  Other 141 23.27 180 29.7   
SES Index in Quartiles      
20.24 
(0.0002) 
                                                    Low 217 35.8 150 24.8  
 Mid-Low 170 28.1 222 36.6  
 Mid-High 94 15.5 109 18  





Tobacco Use      
150.61 
(<0.0001) 
 Non-Smoker 59 9.7 244 40.3  
  Smoker 547 90.3 362 59.7   
Tobacco Packyears 
(PYs) in Quartiles 
Q1 (0-0.125 PYs) 58 9.6 244 40.3 
215.76 
(<0.0001) 
 Q2 (0.125-11.9 PYs) 175 28.9 210 34.7  
 Q3 (11.9-30 PYs) 150 24.8 79 13  
  Q4 (> 30 PYs) 223 36.8 73 12.1   
SHS No  432 71.3 456 75.3 2.42 (0.12) 
  Yes 174 28.7 150 24.7   
Ventilation None 202 33.3 250 41.2 8.13 (0.004) 
  Window/Chimney 404 66.7 356 58.8   
Level of Smokiness Low 42 6.9 35 5.8 3.68 (0.29) 
 Mid-Low 90 14.9 108 17.8  
 Mid-High 166 27.4 146 24.1  
  High 308 50.8 317 52.3   
Separate Kitchen No 93 15.3 129 21.3 7.15 (0.008) 
  Yes 513 84.7 477 78.7   
TB Status Negative 
518 85.5 562 92.7 
16.46 
(<0.0001) 























ORb 95% CI 
        
CRHAP 
Exposurea 
No 31 42 1.00 - 
Yes 575 564 1.78 1.01-3.15 
Smoking Status 
Never 59 244 1.00 - 
Ever 547 392 5.57 3.93-7.87 
Age   606 606 1.03 1.01-1.04 
Gender 
Male 338 380 1.00 - 
Female 268 226 2.07 1.58-2.72 
TB Status 
Negative 518 562 1.00 - 
Positive 88 44 2.25 1.47-3.44 
SES 
Low 217 150 1.00 - 
Mid-Low 170 222 0.56 0.40-0.78 
Mid-High 94 109 0.49 0.32-0.72 
High 125 125 0.57 0.39-0.83 
SHS Exposure 
No 432 456 1.00 - 
Yes 174 150 1.34 1.01-1.80 
a=CRHAP includes coal, wood, and biomass 



































Q1 241 268 1.00 - 
 
201 122 1.00 - 
 
40 146 1.00 - 
Q2 101 149 0.89 0.59-1.35 
 
94 97 0.83 0.50-1.37 
 
7 52 1.21 
0.41-
3.54 
Q3 103 104 1.10 0.70-1.74 
 
99 76 0.93 0.55-1.58 
 
4 28 2.74 
0.65-
11.53 
Q4 153 77 1.71 1.07-2.74   145 62 1.23 0.73-2.09   8 15 10.26 
2.47-
42.68 
      
p-trend 0.05 
      
p-trend 0.6 
  
    
p-trend 0.01 
* Adjusted for age, sex, ethnicity, SES, TB status, SHS,  total pack years                                     
** Adjusted for age, sex, ethnicity, SES, TB status, SHS                       





Chapter 7:  Synthesis 
 
To achieve our specific aims, we utilized previously collected data in a 
highly exposed population in Nepal.  As described previously, we used a 
combination of questionnaire based data and biologic samples to test our 
hypotheses.   Using various statistical approaches and well established laboratory 
methods, we feel confident that our results can contribute significantly to future 
research projects aimed at exposure reduction efforts focusing on CRHAP from 
biomass fuels and the differential influence of traditional tobacco products.  More 
importantly, these results can be utilized by public health professionals aiming to 
reduce disease incidence and prevalence by targeted intervention-based 
approaches.   
Ethnic Variability in Consumption of Traditional Tobacco Products and Lung 
Cancer Risk in Nepal  
 
In this dissertation, we described the differential impact of traditional 
tobacco use on lung cancer risk among ethnic groups in Nepal.  In our first 
manuscript, we described how differential use of tobacco across ethnic groups in 
Nepal can lead to varying risk of lung cancer.  We created individual regression 
models for each ethnic group to analyze lung cancer risk specific to the group.  





to traditional tobacco products when compared to the non-smoking population.  In 
doing this analysis, certain trends began to materialize that added further evidence 
of the deleterious effects of traditional tobacco products.  The highest and most 
dramatic increases in lung cancer risk was observed among those who reported 
using traditional tobacco and those who reported using multiple tobacco products 
across all ethnic groups.  While we expected the risk to be increased among these 
populations, we did not expect the increases to drastically different.          
We are confident that our results can be generalized and extrapolated to 
other similar LMICs.  While we understand cultural differences, our results can be 
used to inform on the ground tobacco cessation, reducing tobacco use initiation 
among teens, and overall educational outreach programs surrounding tobacco use.  
Our results highlight the need to include cultural competent inclusive messaging 
that includes or even prioritizes traditional tobacco products especially among the 
most vulnerable populations.   
Historically, tobacco cessation and health messaging have targeted 
commercial tobacco cigarettes produced by large, multi-national companies.  In 
the United States, successful legislative actions have limited or altogether 
eliminated tobacco advertising especially to young adults and teenagers who are 
more likely to start smoking.  While these successes have been achieved, the 
implications have been isolated to high income countries.  In LMICs, many 





Some challenges include, but are not limited to varying cultural connections to 
tobacco, prioritization, wide-spread acceptance of tobacco use, limited resources, 
and cyclic poverty.  As described in this dissertation, traditional tobacco use is 
more common among rural, poor populations where there is a misplaced 
perception of safety and it is within this framework which lies the opportunity to 
make significant impacts.   
 
 
Urinary Metabolites of 1,3 Butadiene as Biomarkers of CRHAP Exposure from 
combustion of Biomass Fuels – Findings from Nepal 
 
Our aim of using metabolites of 1,3 butadiene provided insight into 
measuring personal exposure to CRHAP originating from the combustion of 
biomass fuels.  As mentioned earlier, a large research gap exists in the current 
scientific literature regarding biomarkers of exposure for CRHAP from biomass 
fuels.  Attempts have been by many researchers targeting other metabolites and 
chemicals yielding mixed results.  Our results are unique in that they provide 
evidence that MHBMA may be a useful non-invasive biomarker especially among 
the non-smoking population.     
As with any biomarker based projects, many benefits and challenges exist.  
While biomarkers are a useful means of measuring overall personal exposure to 
environmental chemicals, difficulties arise when attempting to investigate or 





population provided a unique opportunity to target MHBMA and DHBMA as our 
population was mainly in rural, low income environments.  We used a variety of 
statistical approaches to eliminate the other known contribution to personal 
MHBMA and DHBMA concentrations to garner a clearer picture to the 
contribution of CRHAP from the combustion of biomass fuels. 
While these results are unique to our study population, we are confident 
that similar investigations can be completed in other countries and environments 
using urinary MHBMA as a measure of personal exposure to CRHAP from 
biomass fuels.  Using biomarkers of exposure, researchers can be able to compare 
the efficiency and effectiveness of various cook stoves aimed at CRHAP 
reduction.  The detection and validation of a biomarker of exposure to CRHAP 
from biomass fuels is a necessary first step in the ultimate reduction of diseases 
attributed to this wide-spread environmental exposure.     
 
 
Urinary Biomarkers of CRHAP Exposure from combustion of Biomass Fuels and 
Lung Cancer Risk  
 
In this chapter, we investigated the association between 1,3 butadiene 
metabolites and lung cancer risk.  As expected, we did not see any association 
between the metabolites concentrations and risk of lung cancer.  These results are 
not entirely unexpected as biomarkers of exposure tend to be very transient in 





exposure to environmental pollutants, in this case 1,3 butadiene via CRHAP 
exposure from biomass fuels, but are not as reliable in predicting chronic diseases 
such as cancer.  Cancer has a long latency period in which the contributions of 
many environmental chemicals play a cumulative role.  It can be argued that 
measuring a recognized human carcinogen such as 1,3 butadiene in a CRHAP 
exposure assessment strategy can be useful in predicting cancer risk in certain 
situations.  This can be especially true if the study population tends to be 
stationary and static in which participants report a single, long term residence 
with little to no change in cooking fuels, ventilation, or other known contributing 
factors to CRHAP.  In this setting, a measurement of recent exposure can 
potentially be reflective of a person’s long term, repeated exposure.  Here, we 
may be able to surmise that the daily, repeated exposure to the measured 
carcinogen can contribute to carcinogenesis or lead in that direction when 
controlling for many confounding variables.  In our study, about 50% of our study 
population reported living in multiple residences and the median years spent at the 
most recent reported residence is 45.  After conducting this analysis, we feel that 
our study population did not fit the static, stationary characteristics to make a 










In regards to CRHAP and biomass cooking fuels, recent estimates have 
shown the highly detrimental health impacts of using biomass cooking fuels in the 
home (Buchner and Rehfuess, 2015; Desai et al., 2004; IARC, 2010a; Kan et al., 
2011; Lim et al., 2012; Lim and Seow, 2012; Naeher et al., 2005; Rehfuess et al., 
2009; Sapkota et al., 2013, 2008; WHO, 2007).  Not only does using biomass 
cooking fuel contribute negatively to health, it also has severe ecological impacts.  
Deforestation, loss of animal habitat, reducing agricultural productivity, and 
contributing to climate change are just some of the more wide-spread 
complications of biomass fuel use.  In our projects, we aimed to investigate the 
role of using biomass cooking fuels and the risk of lung cancer.  Similar to 
tobacco, some fuels such as coal, is a well-known and documented human 
carcinogen while other biomass fuels, such as wood, are not well understood.  
Here, our main interest was creating a lifetime profile of fuel use and investigate 
the relationship to lung cancer.  Our results show that using biomass cooking fuels 
is a major risk factor for lung cancer especially among the non-smoking 
population.  This increase in risk among the non-smoking population reveals the 
true contribution of CRHAP originating from the combustion of biomass fuels to 
lung cancer risk.  Furthermore, these results can potentially be extrapolated to 
other LMICs with similar exposures.  As mentioned previously, our results can be 
used to inform future research projects aimed at exposure and disease reduction.  





create more efficient cook stoves with improved ventilation that can greatly 
reduce CRHAP from biomass fuels and ultimately disease. 
Lastly, we investigated how changing fuel types can influence lung cancer 
risk.  In this analysis, we identified the participant’s last and penultimate 
residences and the fuel used in each.  We categorized the fuel change into 
categories reflecting whether the change was biomass-modern fuel, modern-
biomass fuel, or no change at all as well as calculated the number of years since 
that change occurred.  Our working hypothesis was that lung cancer risk will 
decrease directly with years since a biomass to modern fuel change.  We expected 
to see lung cancer risk decrease once the biomass fuel exposure was removed and 
that this decrease will occur linearly over time.  Following analysis, we did not 
see any significant evidence of a decrease in lung cancer risk among the 168 study 
participants who reported such fuel change.  Among this group, the median years 
since biomass-modern fuel change was only 15 years which may not be enough 
time to observe a change in risk.  Conversely, very few participants reported 
switching from a modern to a biomass fuel (~1%).  These fuel changes and 
subsequent health outcomes is important in the sense that biomass fuel use is 
often used as an informal metric of a county’s overall development.  Higher 
percentage of biomass fuel use is often correlated to a lower level of economic 







Overall Synthesis and Future Research 
 Taken together, this dissertation highlights important environmental 
factors that significantly contribute to morbidity and mortality in low and middle 
income countries (LMICs).  Recent studies and estimates have shown that many 
infectious and chronic diseases are projected to increase in LMICs even though 
well-known behavioral factors, namely tobacco smoking, are declining.  Of major 
importance are lung cancer and other respiratory diseases such as tuberculosis 
(TB).  The influence of traditional tobacco products and CRHAP from biomass 
cooking fuels on such respiratory diseases is not well understood.  Similarly, 
recent publications have highlighted the need for improved exposure assessment 
tools to understand personal exposures to CRHAP from biomass cooking fuels 
(Clark et al., 2013; Martin et al., 2013; Rylance et al., 2013).  The ability to 
accurately measure personal exposures to environmental pollutants is the first step 
in reducing hazardous exposures and associated negative health effects.  The best 
tool to achieve this accuracy and reliability is via non-invasive biomarkers of 
exposure.  Many attempts have been made to test various biomarkers in various 
human media and settings, but no consensus has been reached (Clark et al., 2013; 
Rylance et al., 2013; Simpson and Naeher, 2010).  The concern surrounding 
previously underestimated or otherwise not well understood environmental 





been growing.  The aim of this dissertation was to investigate the influence 
traditional tobacco products and CRHAP from biomass fuels on lung cancer risk 
and to investigate biomarkers of exposure to CRHAP.   
In a larger sense, recent events have highlighted a growing global 
commitment to the reduction of fossil fuel use in all sectors, including biomass 
fuels in the home, in an effort to reduce the impacts of a changing climate.  Early 
contentions following these announcements have place the LMICs at a 
disadvantage.  Historically, the now high income/developed world built itself 
upon the use of fossil fuels to spawn and incubate early technology and economic 
development.  While we are now seeing the cumulative climactic impacts of the 
prolonged extortion of our environment, the high income areas are desiring 
cleaner solutions to our dependence on fuels.  It is these climate goals placed 
upon resource starved LMICs that make such global efforts difficult and the old 
“top down” global development/health paradigm still firmly rooted in 
international relations.  Better solutions are needed that start at the household 
level in the most vulnerable global populations.  Starting with advancements in 
cook stove technology to increase efficiency and output with the ultimate goal of 
providing methods that are completely renewable.  It cannot be stressed enough 
that the success of many project like cook stove interventions are heavily 
dependent on a “community based” rather than “community placed”.  In cook 





account.  The type of cooking, type of fuel, cooking styles, cultural cuisines, and 
many others can determine the characteristics of the type of stove that will 
succeed in this area.  There is not a “one size fits all” solution to CRHAP derived 
from biomass fuels for cooking and/or heating, but with targeted efforts by both 
communities and scientists, solutions can be reached.  Such efforts need to 
include LMICs from the very beginning and at all critical decision points to 
ensure their voices are not stifled and true multilateral change achieved.                 
The cocktail of chemicals of which we are exposed to every day make 
isolating source specific contributions difficult.  An improved project for isolating 
and measuring personal exposure to CRHAP from biomass fuels must include 
multiple ambient air measures and multiple biologic samples taken at various time 
points.  Such time points need to include the following: baseline for comparison, 
during fire making/pre-cooking process, during cooking, immediately following 
cooking, during fire burn out, and at time points following to measure chemical 
clearance and other toxicokinetic properties.  Chemical half-life is something that 
needs to be kept in the forefront of any similar project.  The ability to accurately 
and reliably measure personal exposure in a non-invasive manner is imperative to 
testing the efficacy of cook stoves.  Ultimately, cook stoves need to be evaluated 
not by ambient air measures, rather by personal exposure metrics such as 





comparison with the goal of reducing exposures and subsequent diseases related 
to CRHAP from biomass cooking fuels.  
In conclusion, chronic diseases such as lung cancer continue to grow 
across LMICs.  It is in these areas where extreme poverty collides with a lack of 
resources to create an incubator for disease.  Environmental health concerns 
surrounding using biomass fuels and continued tobacco use can be classified 
among the top health priorities.  In this dissertation, we investigated the how the 
use of traditional tobacco impacts lung cancer risk ethnic groups differentially as 
well as the influence of biomass cooking fuels on lung cancer risk.  Lastly, we 
attempted to measure personal level exposure to CRHAP derived from biomass 
cooking fuels using urinary biomarkers and analyze these biomarkers as related to 
lung cancer risk.  Taken together, these manuscripts shed an important light into 
highly impactful environmental factors that contribute significantly to lung cancer 
risk in Nepal.  As noted, these manuscripts lay the groundwork for more in-depth 
studies on traditional tobacco and biomass fuel use on a variety of respiratory 
diseases in different areas.  It is difficult to extrapolate our findings to other 
countries or regions as many cultural, social, and environmental factors contribute 
to the exposure-disease relationship; however, we feel that our results are 
certainly reflective of those faced by millions of Nepali adults.  We hope that this 





health interventions aimed at exposure reduction.  It is in this context that lives 







 As part of my overall doctoral program, I was able to participate in a 
number of projects not directly related to my dissertation project.  The outcome of 
one of these projects was the publication presented here.  While not related to 
CRHAP from biomass fuels, we investigated an indoor aerosol environment in 
Washington DC.  This manuscript was published in Environmental Research in 
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Abstract 
Background: Many young children in the U.S. spend a significant portion of their 
day in child care facilities where they may be exposed to contaminants linked to 
adverse health effects. Exposure data on volatile organic compounds (VOCs) and 
particulate matter (PM) in these settings is   scarce. 
Objective: To guide the design of a larger exposure assessment study in urban 
child care facilities, we conducted a pilot study in which we characterized indoor 
concentrations of select VOCs and PM. Methods: We recruited 14 child care 
facilities in the District of Columbia (Washington, DC) and measured indoor 
concentrations of seven VOCs (n = 35 total samples; 2–5 samples per facility): 
benzene, carbon tetrachloride, chloroform, ethylbenzene, o-xylene, p-xylene, and 
toluene in all facilities; and collected real-time PM measurements in seven 
facilities. We calculated descriptive statistics for contaminant concentrations and 
computed intraclass correlation coefficients (ICC) to evaluate the variability of 





information on the children at- tending these facilities, and information on general 
housekeeping practices and proximity of facilities to potential sources of target 
contaminants. 
Results: We detected six of the seven VOCs in the majority of child care facilities 
with detection frequencies ranging from 71% to 100%. Chloroform and toluene 
were detected in all samples. Median (range) concentrations for toluene, 
chloroform, benzene, o-xylene, ethylbenzene, and carbon tetra- chloride were: 5.6 
mg/m3 (0.6–16.5 mg/m3), 2.8 mg/m3 (0.4–53.0 mg/m3), 1.4 mg/m3 (below the 
limit of detection or <LOD – 4.4 mg/m3), 1.1 mg/m3 ( <LOD – 35.7 mg/m3), 1.0 
mg/m3 (< LOD – 28.5 mg/m3), and 
1.0 mg/m3 (< LOD – 1.6 mg/m3), respectively. The ICCs for the VOCs measured 
ranged from 0.32 to 0.75. Child care facility median concentrations for PM2.5 and 
PM10 were 20.1 mg/m3 and 26.3 mg/m3, respectively. Chlorine bleach, a source 
of chloroform, was used in almost all facilities, air fresheners and/or scented 
candles were used in half of the facilities, and at least one child in each facility 
had physician- diagnosed asthma (median asthma prevalence rate 10.2%). 
Conclusion: We found quantifiable levels of VOCs and PM in the child care 
facilities sampled. Given that exposures to environmental contaminants during 
critical developmental stages may have long lasting impacts on children's health, 
larger studies are needed to characterize and identify sources of exposures to these 










Most infants and young children in the United States spend a significant portion 
of their day in child care facilities. In the U.S., an estimated 6 million children 
under the age of five years are cared for at child care facilities (i.e., child care 
centers, nursery schools, preschools, and family home daycares) with some 
children attending for as much as 50 hours a week (Bureau U.C., 2011; Ax- elrad 
et al., 2013). Limited studies have characterized various in- door air contaminants 
previously linked to adverse health effects, including volatile organic compounds 
(VOCs) and particulate matter (PM) in childcare settings (Bradman et al., 2012;  
Canha et al., 2015; Fritz and Herbarth, 2001; Roda et al., 2011; St-Jean et al., 
2012; Fromme et al., 2005; Kabir et al., 2012; Mainka and Zajusz-Zubek, 2015). 
Exposure to VOCs and PM in children has been linked to respiratory effects such 
as decreased lung function, inflammation,   and   airway  obstruction;   to   
increased allergen sensitization; and to the exacerbation of pre-existing 
respiratory conditions such as asthma (Goldizen et al., 2016; Harving et al., 1991; 
Koren et al., 1992; Mortimer et al., 2008; Norback et al., 1995; Salvi, 2007; 





experience chronic exposures to potentially deleterious contaminants during 
critical windows of development. 
Exposures to environmental contaminants during early stages of development 
may have long lasting health impacts in infants and young children. Children are 
more vulnerable to the potential effects of indoor air contaminants because, 
compared to adults, they have higher respiratory rates and breathe a larger volume 
of air per unit body weight (ATDSR, 2015; USEPA, 2011). Additionally, due to 
their increased physical exertion, infants and young children tend to breathe more 
through their mouths allowing a greater volume of pollutants to be inhaled and 
reducing the effectiveness of one level of filtration (USEPA, 2011; Mott et al., 
1997). They are also more vulnerable to environmental exposures because their 
major systems are still developing. In fact, their lungs are not fully developed 
until adolescence (De Luca et al., 2010; ER et al., 2000; Pinkerton, 2000). 
Children also play on the ground and their height places their breathing zones 
close to the floor which results in higher inhaled doses of select pollutants (e.g., 
toxic gases that are denser than air and layer close to the floor) than an adult 
would receive in the same room (ATDSR, 2015; USEPA, 2011). 
VOCs in indoor environments may originate from several sources including 
building materials and furnishings (e.g., treated wood, (ATDSR, 2007; Brown, 
1999; Yoon et al., 2011; Zuraimi et al., 2004)  paint,  (Yoon  et  al.,  2011;  





Hodgson et al., 2000) furniture, (USEPA, 2011; Brown, 1999; Yoon et al., 2011; 
Zuraimi et al., 2004) and carpet/flooring (Hodgson et al., 2000; Katsoyiannis et 
al., 2008); consumer products (e.g., electronics and toys) (ATDSR, 2010; 
Hodgson et al., 2000; Katsoyiannis et al., 2008; Adgate et al., 2004; Destaillats et 
al., 2008; Tirendi et al., 2009); cleaning supplies (e.g., disinfecting and sanitizing 
products) and deodorizers; (Nazaroff and Wescheler, 2004) and art supplies 
(Bradman et al., 2012; ATDSR, 2015; Mishra et al., 2015). Factors such as age 
(Jia et al., 2008) and structural quality of the facility (Wieslander et al., 1997; Cox 
et al., 2002; Wilke et al., 2004; Wan-Je and Sohn, 2009) as well as maintenance 
and cleaning practices (Nazaroff and Wescheler, 2004; Singer   et al., 2006; 
Wolkoff et al., 1998) could also affect VOC levels in- doors. For example, poorly 
maintained facilities may be more prone to mold and pests potentially leading to 
frequent use of pesticides, which have been linked to higher VOC levels indoors 
(Gordon et al., 1999; Ott and Roberts, 1998; Neal and Spurlock, 2014; Chin et al., 
2014). Proximity of the facilities to roadway traffic, gas stations, parking garages, 
or dry cleaners could also have an effect on the indoor air quality and impact 
indoor VOC and/or PM concentrations (Goyal, 2009; Guo et al., 2010; Janssen et 
al., 2001, 2003; van Vliet et al., 1997; Kheirbek et al., 2012; Kwon et al., 2006; 
Roda et al., 2013). PM may also be present on indoor floors/surfaces primarily 
from dust tracked indoors and outdoor air particles, which may be resuspended in 





While limited studies conducted in Canada, Europe, and Asia have reported the 
presence of some VOCs (Canha et al., 2015; Fritz and Herbarth, 2001; Roda et 
al., 2011; St-Jean et al., 2012; Yoon et al., 2011; Zuraimi and Tham, 2008) and/or 
PM (Canha et al., 2015; Fromme et al., 2005; Kabir et al., 2012; Mainka and 
Zajusz- Zubek, 2015; Beamer and Castaño, 2002) in child care settings, there is a 
dearth of data on VOCs and PM within U.S. childcare facilities (Bradman et al., 
2012; Beamer and Castaño, 2002). Results from one U.S. study conducted in 
northern California by Bradman et al. (2012) indicate that several pollutants in 
child care facilities, including PM and VOCs such as chloroform, benzene, and 
ethylbenzene, reached exposure levels of concern (i.e., estimated exposures 
exceeded government health-based dose or exposure benchmarks). Many of the 
chemicals that reached levels of concern are also known carcinogens, are 
endocrine disruptors, may exacerbate asthma and other respiratory illnesses, and 
may alter neurocognitive functioning in children (Bradman et al., 2012). Another 
study conducted in California measured PM10 concentrations in one university 
child care center (Beamer and Castaño, 2002) and reported that children were 
exposed to higher amounts of PM10 than the adults in the same room. Although 
the Bradman et al. study (Bradman et al., 2012) provided baseline exposure levels 
for several contaminants in child care facilities in northern California, much 
remains to be known about the extent of exposures in these environments and 





the design of a larger exposure assessment study in child care facilities, we 
conducted a pilot study in which we characterized indoor concentrations of seven 




Materials and methods 
 
Child care facility recruitment 
 
In collaboration with the Children's Environmental Health Network, 
approximately 314 child care center directors in the District of Columbia 
(Washington, DC) were initially contacted via email and letters between the Fall 
of 2012 and the Fall of 2013. Study staff followed up with Center Directors who 
responded to emails and letters to be briefed on the pilot study, determine their 
eligibility, and assess their willingness to participate. Recruitment of facilities for 
our study was a challenge due to limited resources (e.g., the lack of full time study 
staff available to focus on outreach and recruitment efforts) and general resistance 
from Center Directors to enroll in the study. Thus, our final sample size consisted 
of a convenience sample of 14 child care facilities. Eligible child care centers 





questionnaire and provide researchers with access to the facility to conduct indoor 
environmental air sampling. For their participation, child care facilities were 
provided education materials on how to reduce indoor environmental exposures 
upon completion of the study. The University of Maryland Institutional Review 
Board reviewed and approved all study protocols and written informed consent 




Study staff administered a questionnaire to child care Center Directors to collect 
information on the number of children cared for at the facility and information on 
other factors that may have influenced indoor contaminant concentrations 
including proximity of the facility to major highways, dry cleaning facilities, 
industrial sites, and gas stations. For one facility, the Center Director was not 
available to complete the questionnaire so the Facilities Manager completed the 
questionnaire with prior authorization from the Center Director. We also queried 
Center Directors to collect information on the physical characteristics of the 
building such as heating sources, whether there was a garage attached to the 
facility, if any recent remodeling/painting had taken place, and information on 
general housekeeping practices and usage of air fresheners, scented candles, and 





physician-diagnosed  asthma  at  each  facility  and  whether  there  were  any 
reports of children experiencing asthma attacks and/or wheezing episodes in the 
three months prior to sampling. 
 
Air sample collection 
 
To characterize VOCs within the facilities, we collected between two and five 10-
h air samples inside the 14 child care facilities using SKC AirChek XR 5000 
model 210 pumps (SKC Eighty Four, PA) fitted with SKC Anasorb Coconut Shell 
Charcoal sampling tubes (catalog # 226-09, SKC Inc, Eighty Four, PA). The total 
number of samples collected per facility was based on the facility size (e.g., in the 
case of large facilities with multiple floors, multiple monitors were used to collect 
a more comprehensive sample); we collected at least two samples per facility to 
ensure complete sample collection in the case of equipment failure and to assess 
indoor variability of VOC concentrations. The VOCs measured and their 
respective limits of detection (LOD) included: benzene (0.50 mg/m3), carbon 
tetrachloride (0.56 mg/m3), chloroform (0.29 mg/m3), ethylbenzene (0.45 
mg/m3), o-xylene (0.72 mg/ m3), p-xylene (0.45 mg/m3), and toluene (0.35 
mg/m3). Selection of these VOCs was based on their potential to impact health 
and presence of known indoor sources. Prior to sampling, pumps were calibrated 





in triplicates. Monitors were positioned on a tripod at an approximate height of 
24–30” to represent the breathing zone of a child. 
To assess exposure to PM we used a DUSTTRAK II Aerosol Monitor (TSI, 
Shoreview, MN) to measure real-time PM2.5   and 
PM10 (i.e., particles with an aerodynamic diameter 2.5 μm and 10 μm, 
respectively) in seven child care facilities. Concentrations of PM2.5 and PM10 
were recorded every minute for 10 h for five facilities (n 600 measurements per 
child care facility), for four hours and 10 min for one facility (n  250 
measurements), and for 45 min in one facility. Equipment malfunction during the 
study limited our ability to measure PM in all facilities and for the full 10 h. For 
our analyses, we excluded data from the childcare facility where PM was only 
measured for 45 min. All environmental samples (VOCs and PM) were collected 
from highly trafficked areas where children spent the majority of their time. 
 
Laboratory analyses of VOCs 
 
Prior to analysis, the charcoal tubes were spiked with 20 μl of an internal standard 
(AccuStandard Cat# CLP-PI-2.5X). The char- coal tubes were broken and the 
content transferred to 4 mL vial, to which a 2 mL of a 50:50 mixture of carbon 
disulfide and acetone was added. The samples were then sonicated for 30 min. 





liquid supernatant was removed for analysis. The VOC samples were analyzed 
using Shimadzu QP2010 gas chromatograph mass spectrometer (GC/MS) 
(Shimadzu Biotech, Columbia, MD) in selective ion monitoring mode as 
previously described by Sapkota et al. (2006). Chromatographic separation was 
achieved using a Restek Rtx-624 column, 60 m x 0.25 mm ID with 1.4 mm film 
thickness (Restek Corp., catalog no. 10969). We deployed field blanks and 
laboratory blanks to check for potential contamination during the shipment 
process or inside the     lab. 
 
Quality assurance/quality control (QA/QC) of VOC sample analyses 
For QA/QC purposes, we collected multiple field blanks (20% of total samples 
collected). These blank samples were analyzed using identical laboratory methods 
as those used for the study samples. All results were corrected for field blanks. 
We determined the percent recovery for all individual VOCs by spiking a known 
con- centration of VOCs to a clean sampling tube, and extracting them as 
described previously. The percent recovery rate was determined as the amount of 
VOCs recovered divided by the spiked amount, which ranged from 59 to 102%. 
We determined the LODs following the Code of Federal Regulations, part 136, 
Appendix B (https:// www.law.cornell.edu/cfr/text/40/part-136/appendix-B) 
(Protection of Environment, 2014). Briefly, we analyzed seven spiked samples 





these spiked samples was multiplied by the Student's t-value associated with the 
99% confidence interval and 6 degrees of freedom. Sample concentrations below 
the LOD were imputed to LOD/2 (Finkelstein and Verma, 2001) and corrected for 
percent recovery. 
 
2.5.   Statistical analysis 
 
We first summarized general facility characteristics and housekeeping practices. 
For VOCs, given multiple air samples were collected from each child care 
facility, we first calculated the arithmetic mean concentration for each VOC in 
each facility. We then calculated descriptive statistics using the respective VOC 
average concentration for each facility. If at least one sample for the child care 
facility had a concentration 4LOD then this analyte was considered detected. To 
evaluate the within- and between- facility variability and reproducibility of VOC 
concentrations, we also calculated intraclass correlation coefficients (ICC) using 
mixed effects models (Rabe-Hesketh and Skrondal, 2012). An ICC 40.75 
indicates excellent reproducibility (i.e., concentrations are consistent from 
sample-to-sample and a single measurement sufficiently represents the average of 
the series of measurements over a specific time period), an ICC value between 0.4 
and 0.75 indicates fair to good reproducibility, and an ICC of o0.4 indicates poor 





facility variability of VOC concentrations and that more samples per facility are 
needed to properly characterize indoor VOC exposure for the sampling period. 
Log 10-transformed VOC concentrations were used to calculate ICCs. 
The real-time PM instrument used provided time-resolved PM measurements (i.e., 
particle count and concentration) at 1 min intervals. We calculated descriptive 
statistics for each center and used these center level measurements to calculate 
average PM concentrations across centers. We also assessed mean hourly PM 
concentrations at each facility to evaluate time trends in concentrations. We 
performed all statistical analysis in Stata 13.0 for Windows (StataCorp LP, 





General child care center characteristics 
 
With the exception of two facilities, which served children up to age 12 years, the 
majority of child care centers (85.7%) served children between the ages of 6 
weeks and 5 years. The number of children attending the child care centers ranged 
between 15 and 193 children (Mean 78.0 children). Among child care centers 





attending was 160. General characteristics for participating child care facilities are 
presented in Table 1. Most of the child care centers were located in a commercial 
building (78.6%) and over half of the center respondents (64.3%) indicated that 
pesticides were applied on the premises for pest control. Half of the child care 
center respondents also reported that air fresheners and/or scented candles were 
used onsite and almost all center respondents (92.9%) stated that chlorine bleach 
(sodium hypo- chlorite, a source of chloroform) was used for sanitizing different 
surfaces in the facility. The most commonly reported surfaces sanitized with 
chlorine bleach included tables, bathrooms, and chairs, though respondents also 
reported the use  of  chlorine bleach to sanitize beds, changing tables, and 
children's toys. Over half (64.3%) of the child care centers were located more than 
10 blocks from the nearest highway or dry cleaning facility  and within five 
blocks from the nearest gas station. Approximately 30% of the facilities had 50% 
or more of usable carpeted indoor space (data not shown). While the majority of 
the facilities were located in an inner-city urban setting, only three facilities were 
near roads with heavy traffic and only one facility had an attached garage. Paint 
removal or remodeling activities within the prior two years of sampling was 
reported in 71.4% of the facilities; two Center Directors reported that painting 
was done while children and staff were present in the facility. 
Center Directors from 13 of the 14 facilities sampled were able to provide 





child care facility respondents reported having at least one child experience an 
asthma attack and a wheezing episode, respectively, within three months prior to 
sampling. Interestingly, all 13 child care facilities from which we collected health 
data had at least one child with physician-diagnosed asthma; 53.8% of the centers 
had at least 5 children with physician- diagnosed asthma. One center serving 89 
children be- tween the ages of 6 weeks and 5 years reported having 25 (28.1%) 
children with physician-diagnosed asthma who were also taking asthma 
medication. The Center Director for this facility also re- ported that 5 children 
experienced asthma attacks and 10 children had wheezing episodes within three 
months prior to sampling. This facility was located less than one block away from 
the nearest highway and the Center Director also reported heavy traffic in close 
proximity to this facility. Overall reported physician-diagnosed asthma prevalence 
was 7.9% (median: 10.2%; range: 0.63– 28.1%); overall reported prevalence of 
children experiencing an asthma attack in the prior three months was 1.1%. 
 
VOC and PM concentrations 
 
We collected a total of 35 air samples from 14 child care facilities (two samples 
were collected from each of 11 child care facilities, four samples from each of 
two child care centers, and five samples from one center) serving 1092 children. 





exception of p-xylene, all VOCs measured had a detection frequency greater than 
70%. Toluene and chloroform were detected in every child care facility. Median 
(range) concentrations for toluene, chloroform, benzene, o-xylene, ethylbenzene, 
and carbon tetrachloride were: 5.6 mg/m3 (0.6, 16.5 mg/m3); 2.8 mg/m3 (0.4, 
53.0 mg/m3), 1.4 mg/m3 ( <LOD, 4.4 mg/m3), 1.1 mg/m3 ( <LOD, 35.7 mg/m3), 
1.0 mg/m3 ( < LOD, 28.5 mg/m3), and 1.0 mg/m3 ( <LOD, 1.6 mg/m3), 
respectively. 
Table 3 indicates the variability of concentrations between and within-facilities 
along with the respective ICCs for the VOCs measured and detected in more than 
one child care facility. The ICCs ranged from 0.32 to 0.75. Most of the variability 
in concentrations for benzene, chloroform, and toluene was largely due to 
between-facility differences suggesting that one sample may be sufficient to 
characterize exposure to these VOCs during a given day. For example, 25% of the 
variability in concentrations was due to differences within facilities for benzene 
while 26% of the variability was due to differences within facilities for 
chloroform and toluene. For carbon tetrachloride, ethyl benzene, and o-xylene we 
found that most of the variability in concentrations was due to within-facility 
differences (ICC=0.32–0.43) suggesting that multiple samples would be needed to 
properly characterize exposure to these VOCs within a given day. 
Summary statistics for DustTrak PM measurements from six of the child care 





median (range) concentrations were 17.0 mg/m3  (7.0–128.0 mg/m3) and 19.0 
mg/m3  (10.0–207.0 mg/m3), respectively; child care facility median (range) 
concentrations for PM2.5 and PM10 were 18.1 mg/m3 (14.0–34.1 mg/m3) and 
23.9 mg/m3 (15.9–45.1 mg/m3), respectively. Peak median PM2.5 and PM10 
concentrations were observed around 12:00 pm and, in general, concentrations 
seemed to decrease after noon and remain   stable after 5:00 pm (Supplemental 
Fig.  1). 
Discussion 
 
In this pilot study, we characterized indoor concentrations of seven VOCs in 14 
child care facilities and PM in six child care facilities in predominantly inner-city 
areas in Washington, DC. We also collected general information on participating 
facilities including chemical use indoors (e.g., cleaning products, pesticides, air 
fresheners), proximity to potential sources of VOCs and PM, as well as general 
information on the respiratory health of children enrolled at these facilities. All 
but one of the VOCs measured were detected in every center and PM was also 
widely detected in the facilities sampled. 
While limited studies have documented the presence of indoor air pollutants in 
child care settings (i.e., child care/day care centers, nurseries, preschools), to our 
knowledge, this study is one of only two to characterize indoor concentrations of 





facilities. Brad- man et al., (2012) measured several VOCs in 34 California child 
care facilities including the seven VOCs measured in the present study. Compared 
to Bradman et al. (2012), median VOC concentrations in our study were 1.4–1.8 
times higher. Maximum concentrations of frequently detected VOCs in our study 
were up to 14.3 times higher than those reported in California child care facilities. 
Differences in concentrations between these two studies may be due to 
differences in laboratory methods (e.g., limits of detection), quality of indoor 
ventilation in the facilities sampled, proximity of facilities to potential sources of 
target pollutants, and general facility housekeeping practices. For example, we 
detected chloroform (a VOC that may originate, among other sources, from 
consumer products containing chlorine bleach (Board CAR, 1990; Odabasi, 2008) 
in every air sample in our study while it was only detected in 38% of the facilities 
sampled by Bradman et al. (2012). This may reflect higher use of products 
containing chlorine bleach in the facilities we sampled compared to the California 
facilities. Although actual usage of chlorine bleach was not reported in the 
Bradman et al. study, the authors did report that chlorine bleach was stored in 
65% of the facilities sampled. In our study, 92% of the facilities we sampled 
reported using chlorine bleach to sanitize and disinfect various indoor surfaces. 
While effective  sanitation and disinfection is necessary to comply with childcare 
licensing regulations and to reduce the risk of infectious diseases in child care 





sodium hypochlorite) may also lead to elevated levels of indoor pollutants known 
to be respiratory irritants. Additionally, recent increases in the concentration of 
bleach pro- ducts registered by the U.S. Environmental Protection Agency make 
diluting bleach correctly confusing and may expose facility staff to more irritating 
vapors when diluting the products before use. Alternatives for bleach-free 
disinfection and sanitation of surfaces in childcare settings that do not introduce 
other hazards should be explored (Agana, 2013; Program CCH, 2008; USEPA, 
2013). 
Carbon tetrachloride was detected in 86% of the facilities sampled; however, this 
VOC was not widely detected in child care centers in California (Bradman et al., 
2012) where only 3% of the child care facilities sampled had detectable levels. 
Common sources of indoor exposure to carbon tetrachloride include building 
materials or products such as cleaning agents (Odabasi, 2008; ATDSR, 2005). To 
our knowledge, no other studies have assessed indoor concentrations of carbon 
tetrachloride in child care settings in the U.S. or elsewhere. 
Compared with other studies conducted in child care facilities outside the U.S. 
(Fig. 1, Supplemental Table S1), particularly in Canada (St-Jean et al., 2012) and 
France (Canha et al., 2015; Roda et al., 2011), we generally observed comparable 
geometric mean (GM)   concentrations   for   benzene,   while   higher   GM 
benzene concentrations were reported in two studies conducted in Asia (Yoon et 





benzene concentrations compared to those reported in German child care facilities 
by Fritz and Herbarth (2001). For ethylbenzene, we observed similar GM 
concentrations compared to those reported in child care facilities in Canada 
(Montreal) (St-Jean et al., 2012) and France (Paris) (Roda et al., 2011); while 
higher GM concentrations were observed  in  child  care facilities in Clermont-
Ferrand, France (Canha et al., 2015). In general, higher GM concentrations for 
toluene have been reported in child care facilities in other countries including 
Canada, Singapore, and France (Roda et al., 2011; St-Jean et al., 2012; Zuraimi 
and Tham, 2008). With the exception of child care facilities in Singapore 
(Zuraimi and Tham, 2008), we observed slightly higher GM concentrations for o-
xylene in the facilities we sampled compared to child  care  facilities  in  Canada  
and  France  (Canha et al., 2015; Roda et al., 2011; St-Jean et al., 2012). Climate, 
season, location (urban vs. rural), indoor ventilation, sampling collection methods, 
laboratory analyses, building characteristics (e.g., proximity to potential pollutant 
sources), and general housekeeping practices may explain the noted differences 
among these studies; thus comparisons should be interpreted with caution. 
Limited work has been conducted to investigate children's exposure to PM 
specifically in child care settings in the U.S., with the majority of such studies 
conducted internationally. We observed similar mean PM2.5 concentrations 
compared to those reported by Bradman et al. (2012) in 40 child care facilities in 





(2015) in 7 nursery schools in France (2179 μg/m3). The PM2.5 concentration for 
several classrooms and lunchrooms in three nurseries in Portugal, ranged from 
18.7 μg/m3 to 48.94 μg/m3 (Branco et al., 2014) while concentrations ranged 
from 14.0 μg/m3 
to 34.1 μg/m3  in the child care facilities we sampled.     Another study conducted 
in Portugal investigated urban and rural nursery schools and found that PM2.5 
concentrations ranged from 9.91 μg/ m3   to 30.14 μg/m3   across classrooms and 
lunchrooms (Nunes 
et al., 2015). 
With respect to mean PM10 concentrations, we observed lower concentrations 
(33.8 + 22.1 μg/m3) compared to those reported in prior studies conducted in the 
U.S. (California) by Beamer and Castaño (2002) in one university child care 
center (47.3 + 9.4 μg/ m3 and 68.9 + 24.7 μg/m3 in two different classrooms) and 
by Bradman et al. (2012) in 35 child care facilities (54.8 + 32.3 μg/m3). Higher 
mean PM10   concentrations have also been reported in other studies conducted in 
child care facilities in Korea, Poland, and Germany (Fromme et al., 2005; Kabir et 
al., 2012; Mainka and Zajusz-Zubek, 2015). Differences in PM concentrations 
between studies could be due to several factors including differences in 
ventilation, measurement methods (real-time vs. gravimetric), and proximity of 





Bradman et al. (2012) reported that PM2.5 and PM10 concentrations in 11 and 
46%, respectively of the child care facilities they sampled exceeded 24-hour 
standards (i.e., concentrations not to be exceeded in a 24-h averaging period) 
based on state (PM10 = 50 μg/m³) and U.S.  Environmental Protection   Agency 
(USEPA) standards (PM2.5 =  35 μg/m³). In our small pilot study, one child care 
facility exceeded the 24-h PM10 state standard, while no facilities exceeded the 
PM2.5 USEPA standard. However, it should be noted that these standards are 
based on 24-h gravimetric sampling(California Air Resources Board, 2015) while 
we collected real-time PM data and were only able to sample half of the facilities 
recruited for 10 h or less, limiting direct comparisons. Also, our one time sample 
may not be representative of children's daily exposures. 
The use of insecticides can also contribute to indoor VOC levels (Chin et al., 
2014) and although insecticides were not measured in this pilot study, we found 
that over half of the facilities reported onsite applications. Many insecticides are 
neurotoxicants and have also been linked to adverse respiratory effects including 
various respiratory symptoms (e.g., wheezing or whistling in the chest, trouble 
going to sleep due to wheezing or whistling in the chest), and an increased risk for 
cough (Glaser, 2005; Raanan et al., 2015; Salameh et al., 2003). The frequent 
pesticide use reported in the sampled facilities highlights the need for education 
on and adoption of integrated pest management (IPM) to reduce pesticide 





prevention techniques such as removing sources of food and water, and sealing 
possible entryways such as cracks and crevices, to minimize the use of chemicals. 
Least toxic pesticides are used sparingly as a last resort. 
Half of the child care facilities sampled also reported using air fresheners and/or 
scented candles indoors. Air fresheners and candles can also affect indoor air 
quality by emitting VOCs and particulate matter (Singer et al., 2006; Lee et al., 
2014). For ex- ample, Lee et al., (2014) observed significantly higher 
concentrations of benzene, toluene, and ethylbenzene in homes where air 
fresheners were applied compared to homes where they had not been applied. 
Another important observation included the prevalence of physician-diagnosed 
asthma reported in the facilities we sampled. The prevalence of physician-
diagnosed asthma (as reported by Childcare Center Director) ranged between 0.68 
and 28.1% (Median 10.2%). Three out of the 13 childcare Center Directors that 
provided this information reported a higher prevalence of physician-diagnosed 
asthma compared to that reported by the Centers for Disease Control and 
Prevention for children 0-4 years of age in Washington, D.C. (11.4%) (Centers for 
Disease Control and Prevention, 2008) and in the general U.S. population (5.4%) 
(Bloom et al., 2012). 
The main limitation of this study is the sample size, which limits our statistical 
analysis and the power to draw any inferences. Similar to other child care studies, 





recruitment proved to be a challenge, potentially leading to selection bias. Our 
small sample size also limits generalizability of our results. Additionally, most of 
the facilities recruited were in buildings or churches, so we were not able to assess 
exposures in home-based child care centers where children may experience 
different exposures. Like other studies in child care settings, our study only 
provides a “snapshot” of indoor concentrations of the target pollutants measured 
on the days sampled. Thus, concentrations of target contaminants may not reflect 
contaminant levels observed on other days, during different seasons, and/or long-
term averages. Limited resources to conduct this study also prevented us from 
measuring other VOCs and indoor air contaminants. Lastly, information collected 
in questionnaires was self-reported and potentially subject to recall bias. For 
example, we relied on in- formation provided by Center Directors on questions 
related to children's health (e.g., number of children with physician-diagnosed 
asthma) rather than confirming this with parents to obtain more accurate 
information. 
Despite these limitations, our study has several strengths. First, this study is one 
of only two studies in the U.S. to characterize indoor air concentrations for the 
selected VOCs and PM in multiple child care facilities helping to fill a major 
exposure data gap (Bradman et al., 2012). Our study also focused on child care 
environments the majority of which were located in inner-city environments 





already be experiencing disproportionate exposures to environmental 
contaminants. In addition, although we only sampled 14 child care facilities, these 
facilities served a total of 1,092 children; thus, our exposure data provides a 
“snapshot” on indoor child care exposures to a large population of predominantly 
inner-city children. Lastly, we obtained at least two samples per facility allowing 
us to evaluate variability of concentrations within and between facilities and to 
assess whether multiple samples would be necessary in future studies to properly 
characterize indoor exposures to select VOCs. 
There are multiple lessons to be gained from this pilot study. As already noted, 
recruitment of childcare centers was a challenge. Since this pilot study was 
conducted without funding we did not have dedicated staff to help with 
recruitment efforts and relied heavily on letters and mass e-mails. A dedicated 
staff member to call center directors followed by in-person visits to the centers 
would likely improve enrollment considerably as the center di- rectors are pressed 
for time and responding to e-mail for study participation is not their priority. 
Future studies should also con- sider collecting concurrent indoor and outdoor 
samples to better characterize the indoor source contributions. Detailed 
inventories of potential exposure sources including information on frequency of 
use for consumer products would also be useful in informing potential areas of 
intervention. The usage pattern of such products is likely to vary across season 





identify the temporal as well as spatial patterns of such uses to better inform 
targeted exposure mitigation interventions. 
Indoor air quality has been the focus of several studies in an effort to characterize 
and reduce children's indoor environmental exposures; however, few studies have 
focused on child care environments. Our data suggest that children in 
predominantly inner-city environments in the Washington D.C. metro area are 
potentially exposed to elevated levels of VOCs and/or PM in child care facilities. 
Given the amount of time that children may spend in these facilities and their 
unique susceptibility to environmental exposures, educational outreach efforts 
that focus on sustainable strategies to improve indoor air quality in these settings 
is warranted. Future studies are needed to quantify children's individual exposure 
levels of indoor contaminants in such environments to assess the health impact of 
these exposures, and determine if such exposures can be mitigated through 
culturally competent mitigation programs specifically targeted towards child care 
professionals. 
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